Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Impact Factor 13.965
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation Research

  • My alerts
  • Sign In
  • Join

  • Impact Factor 13.965
  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Review

Aging and Autophagy in the Heart

Akihiro Shirakabe, Yoshiyuki Ikeda, Sebastiano Sciarretta, Daniela K. Zablocki, Junichi Sadoshima
Download PDF
https://doi.org/10.1161/CIRCRESAHA.116.307474
Circulation Research. 2016;118:1563-1576
Originally published May 12, 2016
Akihiro Shirakabe
From the Department of Cell Biology and Molecular Medicine, Rutgers–New Jersey Medical School, Newark (A.S., Y.I., S.S., D.K.Z., J.S.); Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Science, Kagoshima University, Japan (Y.I.); Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy (S.S.); and Department of AngioCardioNeurology, IRCCS Neuromed, Pozzilli, Italy (S.S.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshiyuki Ikeda
From the Department of Cell Biology and Molecular Medicine, Rutgers–New Jersey Medical School, Newark (A.S., Y.I., S.S., D.K.Z., J.S.); Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Science, Kagoshima University, Japan (Y.I.); Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy (S.S.); and Department of AngioCardioNeurology, IRCCS Neuromed, Pozzilli, Italy (S.S.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastiano Sciarretta
From the Department of Cell Biology and Molecular Medicine, Rutgers–New Jersey Medical School, Newark (A.S., Y.I., S.S., D.K.Z., J.S.); Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Science, Kagoshima University, Japan (Y.I.); Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy (S.S.); and Department of AngioCardioNeurology, IRCCS Neuromed, Pozzilli, Italy (S.S.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniela K. Zablocki
From the Department of Cell Biology and Molecular Medicine, Rutgers–New Jersey Medical School, Newark (A.S., Y.I., S.S., D.K.Z., J.S.); Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Science, Kagoshima University, Japan (Y.I.); Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy (S.S.); and Department of AngioCardioNeurology, IRCCS Neuromed, Pozzilli, Italy (S.S.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junichi Sadoshima
From the Department of Cell Biology and Molecular Medicine, Rutgers–New Jersey Medical School, Newark (A.S., Y.I., S.S., D.K.Z., J.S.); Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Science, Kagoshima University, Japan (Y.I.); Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy (S.S.); and Department of AngioCardioNeurology, IRCCS Neuromed, Pozzilli, Italy (S.S.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics

Jump to

  • Article
    • Abstract
    • Manifestation of Aging in the Heart
    • Molecular Mechanisms of Aging in the Heart
    • Role of Autophagy During Aging of the Heart
    • Role of Mitophagy
    • Relevant Intracellular Signaling Mechanisms Controlling Autophagy During Aging
    • How to Stimulate Autophagy
    • Concluding Remarks
    • Acknowledgments
    • Sources of Funding
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading

Abstract

The aging population is increasing in developed countries. Because the incidence of cardiac disease increases dramatically with age, it is important to understand the molecular mechanisms through which the heart becomes either more or less susceptible to stress. Cardiac aging is characterized by the presence of hypertrophy, fibrosis, and accumulation of misfolded proteins and dysfunctional mitochondria. Macroautophagy (hereafter referred to as autophagy) is a lysosome-dependent bulk degradation mechanism that is essential for intracellular protein and organelle quality control. Autophagy and autophagic flux are generally decreased in aging hearts, and murine autophagy loss-of-function models develop exacerbated cardiac dysfunction that is accompanied by the accumulation of misfolded proteins and dysfunctional organelles. On the contrary, stimulation of autophagy generally improves cardiac function in mouse models of protein aggregation by removing accumulated misfolded proteins, dysfunctional mitochondria, and damaged DNA, thereby improving the overall cellular environment and alleviating aging-associated pathology in the heart. Increasing lines of evidence suggest that autophagy is required for many mechanisms that mediate lifespan extension, such as caloric restriction, in various organisms. These results raise the exciting possibility that autophagy may play an important role in combating the adverse effects of aging in the heart. In this review, we discuss the role of autophagy in the heart during aging, how autophagy alleviates age-dependent changes in the heart, and how the level of autophagy in the aging heart can be restored.

  • aging
  • autophagy
  • mitochondria
  • mitochondrial degradation
  • NAD
  • oxidative stress

The incidence of cardiovascular disease progressively increases with age in both men (from 10 per 1000 people at 45–54 years of age to 74 per 1000 people at 85–94 years of age) and women (from 4 to 65 per 1000 for the comparable age groups).1 Despite recent progress in cardiovascular treatment, the total prevalence of age-related diseases, including cardiovascular diseases, is still increasing.2 High blood pressure, obesity, and metabolic syndrome increase with age, and these conditions facilitate the development of heart disease, which is a major cause of chronic disability, morbidity, and mortality in the elderly.3,4

Examination of the cell biology of the aging process has revealed that it is often associated with dysfunctional organelles, which trigger oxidative stress, protein misfolding, and cell death and induce precipitous declines in the maintenance of cellular quality control mechanisms.5–7 In particular, an important pathological feature of aging is the development of mitochondrial abnormalities, where reactive oxygen species (ROS) progressively accumulate during aging as a result of damage to mitochondrial proteins, an imbalance between oxidative stress and antioxidant mechanisms and increases in electron leakage from dysfunctional electron transport chains.8–12 Accumulation of ROS induces mutations in mitochondrial DNA (mtDNA) and impedes the tricarboxylic acid cycle and electron transport chain complexes, thereby attenuating the bioenergetic function of mitochondria. This causes a vicious cycle that progressively aggravates oxidative stress and mitochondrial dysfunction.10–12 Prevention of these aging-associated catastrophes requires properly functioning quality control mechanisms that allow elimination and well-coordinated replenishment of damaged proteins and organelles. Cardiomyocytes in the adult heart seem to retain the ability to divide in response to stress, but their proliferation is inefficient. The adult heart is thus greatly reliant on the cellular quality control mechanisms because damaged proteins and organelles cannot be easily diluted through cell division.13,14 Autophagy is an evolutionarily conserved mechanism that targets damaged or long-lived proteins and organelles for degradation through lysosomes.15,16 Autophagy can be either nonselective or cargo specific, and mitochondrial-specific autophagy is referred to as mitophagy. Accumulating lines of evidence support a crucial role for autophagy and mitophagy in the regulation of cardiac homeostasis at baseline and in response to stress,15,17,18 and their downregulation seems to contribute to the aging process16,19,20 in many organs. This review will summarize the current understanding of the role of autophagy in the regulation of aging in the heart. Readers are also referred to recent reviews on similar topics with distinct focuses, such as longevity and metabolism, to better understand the broader functions of autophagy.16,21

Manifestation of Aging in the Heart

Aging hearts exhibit unique histological and biochemical features.22–25 Increases in apoptosis and necrosis, proliferation of myocyte nuclei, increased myocyte volume, and connective tissue accumulation are frequently observed in the myocardium of old animals.26–28 Senescence-associated ectopic β-galactosidase activity and dense bodies with autofluorescence, consisting of damaged proteins and lipid accumulates, called lipofuscin,29 are also increased. In addition, aging affects the abundance of some molecules, including the tumor suppressors p16INK4 and p19ARF.30,31 How do these changes affect cardiac function and susceptibility to heart failure in the elderly? Aging cardiomyocytes are less capable of undergoing compensatory hypertrophy and proliferation in response to increased workload.22,32–35 As a result, aging increases wall stress that is not normalized by ventricular remodeling.36 Furthermore, induction of cell protective mechanisms, such as expression of antioxidant and heat shock proteins, in response to pathological insults is attenuated in aging hearts.33,37,38 Optimal therapeutic interventions to alleviate the adverse effects of aging should prevent cell death and accumulation of senescent myocytes.22 For example, A2E, a major component of toxic lipofuscin, upregulates inflammatory cytokines and chemokines and contributes to the inflammatory response in aging tissues, but activation of autophagy seems to protect the tissue by eliminating both toxic aggregates and activation of inflammation.39 As we discuss later, however, autophagy and autophagic flux are generally downregulated in the aging heart.

Molecular Mechanisms of Aging in the Heart

Because aging increases the risk of diseases and reduces organ function, elucidation of the mechanisms that serve to counteract the adverse effects of aging has significant clinical implications.40 Evolutionarily conserved defined molecular mechanisms are involved in the regulation of lifespan in animals,40–43 and activation of these mechanisms may affect the aging of individual organs and the cells therein. Aging is a multifunctional process, with many mechanisms contributing to functional decline in organs and tissues. Accumulation of damaged proteins and mitochondria is commonly observed in aged cells. In addition, production of ROS in various organs is progressively enhanced over the years, and oxidative stress accumulates during the aging process.10,12 Likewise, increased ROS and accumulation of damaged proteins and organelles in the heart also occur in the presence of high blood pressure and metabolic abnormality, which facilitate senescence in the heart.44,45

ROS progressively accumulate during aging, because of both electron leakage from mitochondria resulting from impaired mitochondrial oxidative phosphorylation and an imbalance between the expression of ROS-producing enzymes and antioxidant proteins.10,46 The accumulated ROS further promote the mtDNA mutations and deletions that accumulate over time, leading to a progressive reduction in mtDNA content.47 ROS can also impair the enzymes involved in oxidative phosphorylation, particularly those containing an iron–sulfur cluster.48 Finally, oxidative stress is associated with mitochondrial permeability transition pore opening, which promotes necrosis and cell death in mammalian cells.49 Mitochondrial dysfunction is a common feature of the aging process,50 and systemic mitochondrial overexpression of catalase extends lifespan and delays the aging process in mice.51 These observations suggest that the accumulation of ROS in mitochondria contributes to the aging process in mammals.52

In addition to electron leakage from the electron transport chain, mitochondrial expression of Nox4, a major intracellular isoform of nicotinamide adenine dinucleotide phosphate oxidase in the heart, is upregulated in the aged heart, contributing to ROS production and the development of cardiac abnormalities in aging mice.53 Nox4 is upregulated by pressure overload through an nuclear factor-κB (NF-κB)–dependent mechanism,54 but the mechanism by which Nox4 is upregulated in the aging heart is currently unknown. It would be interesting to test whether the increased susceptibility of aging hearts to stress is alleviated in cardiac-specific Nox4 knockout mice.55 However, it should be noted that endogenous Nox4 also possesses physiological functions, such as induction of angiogenesis56 and autophagy in response to glucose deprivation57 in cardiomyocytes. Thus, further investigation is required to fully elucidate the role of ROS in the overall responses of the heart during aging.

Mitochondrial stress triggers a series of events, including damage to proteins58 and mtDNA,59 activation of mitochondrial mechanisms of degradation of both individual proteins60 and partial or whole organelles,61 and mitochondrial biogenesis,62 thereby causing a condition in which misfolded proteins accumulate or there is a mismatch between mtDNA-encoded proteins and nuclear-encoded proteins. This condition activates a set of adaptive responses collectively termed the mitochondrial unfolded protein response (UPRmt),63 including the activation of chaperones and other mitochondrial quality control mechanisms such as mitophagy.64 The UPRmt is essential for long-term maintenance of mitochondrial quality and affects many mechanisms known to influence either lifespan or aging.60 Although the UPRmt is evolutionarily conserved and has been studied extensively in Caenorhabditis elegans, the detailed signaling mechanisms found in mammalian cells are poorly understood. Elucidating the molecular mechanisms by which the UPRmt maintains mitochondrial homeostasis and whether the UPRmt acts through autophagy and mitophagy in mammalian cardiomyocytes would be interesting and should provide clues for the development of novel interventions to achieve antisenescence therapy in the heart. It should be noted that endoplasmic reticulum (ER) stress also induces autophagy and a UPR to eliminate misfolded proteins and defective organelles.65 However, the connection between the ER stress and aging is, to date, less well defined than that between the UPRmt and aging.

Increases in oxidative stress induce DNA damage, which, in turn, either induces a series of DNA repair mechanisms or activates either cell death or cellular senescence mechanisms. Increases in DNA damage and defective DNA repair have been shown to inhibit autophagy.66,67 Somatic mtDNA mutation inhibits autophagy, thereby allowing mutated mtDNA to escape degradation and promote mitochondrial dysfunction. When DNA damage induces senescence, it is accompanied by a unique phenotype, called the senescence-associated secretory phenotype,68 that mediates chronic inflammation, thereby further promoting DNA damage and senescence. DNA damage-induced cellular senescence stabilizes GATA4, thereby inducing senescence-associated secretory phenotype through the activation of NF-κB. Interestingly, p62-mediated selective autophagy degrades GATA4, whereas GATA4 is stabilized in human fetal lung fibroblasts undergoing senescence because of suppression of autophagy.69 These observations suggest that autophagy may inhibit the adverse effects of aging by negatively regulating senescence-associated secretory phenotype and aging-associated inflammation.

Telomeres are regions of repetitive nucleotide sequences located at the ends of chromosomes that protect the chromosomal end structures from damage. Each time cells divide, the telomere ends become shorter. Because telomere shortening causes senescence through the activation of the p53 and Rb pathways, the molecular mechanism controlling telomere length is intimately connected to aging.70 Although cardiomyocytes in the adult heart rarely proliferate, telomere damage is also caused by oxidative stress, which, in turn, activates signaling mechanisms leading to senescence.70 Importantly, the health of the heart is dependent on basal turnover of cardiomyocytes generated from cardiac progenitor cells. Telomere attrition and DNA damage induce senescence in cardiac progenitors, resulting in a loss of regenerative capacity and promotion of cardiac senescence.71 It has recently been shown that quiescent satellite cells in skeletal muscles are capable of maintaining their stemness by activating autophagy.72 However, autophagy is attenuated in aged satellite cells, leading to stimulation of senescence through accumulation of oxidative stress and damaged proteins and organelles.72

Another important mechanism regulating senescence is protein acetylation, which is regulated by a balance between protein acetylases and deacetylases. Spermidine, an acetyltransferase inhibitor, prolongs the lifespan of yeast, flies, and nematodes in an autophagy-dependent fashion, by inhibiting protein acetylation of cytoplasmic and nuclear proteins.73 In addition, the sirtuin family of protein deacetylases is particularly relevant in the regulation of lifespan and aging. Sirtuins are a family of 7 NAD+-dependent protein deacetylases known to be involved throughout the evolutionary tree in lifespan extension in response to caloric restriction (CR) and resveratrol, a naturally occurring polyphenol that stimulates Sirt1. The Sirt1 isoform acts in both the nucleus and the cytoplasm,74 and its expression increases in the aging heart, most likely as a compensatory mechanism.75,76 Sirt1 can retard senescence and confer resistance to oxidative stress in the heart75 and promotes autophagy through deacetylation and stimulation of Forkhead box O (FoxO) 1 in cardiomyocytes.77 Sirt1 negatively regulates p66shc expression in human umbilical vein endothelial cells.78 p66shc is a multifunctional adapter protein and its deletion prolongs lifespan in mice.79 p66shc positively regulates oxidative stress by stimulating mitochondrial oxidative phosphorylation and downregulating FoxO-mediated protection against oxidative stress.80–82 Sirt3, a mitochondrial sirtuin isoform, can stimulate oxidative phosphorylation by directly deacetylating the electron transport chain complexes.83 Sirt3 also inhibits pathological cardiac hypertrophy by deacetylating cyclophilin D, a protein that regulates mitochondrial permeability transition pore opening and prevents the adverse effects of aging in the heart.84,85

Mammalian target of rapamycin (mTOR), a serine threonine kinase that regulates protein synthesis, transcription of mitochondrial proteins and autophagy, has also been implicated in the regulation of lifespan and aging.86 mTOR suppresses autophagy through phosphorylation of Unc-51–like autophagy activating kinase 1 (Ulk1), primarily through the activation of mTOR complex 1 (mTORC1).87 mTOR has drawn particular attention in the area of aging because the mTOR inhibitor rapamycin has been shown to increase lifespan in mammals.88 A recent report showed that the activity of mTOR does not increase with age in C57BL/6J mice.89 Although these findings suggest that endogenous mTOR may not be directly involved in the aging process, they nonetheless do not exclude the possibility that the beneficial effects of rapamycin treatment on lifespan are mediated through the suppression of endogenous mTOR.

A recent study found that serum levels of GDF11, a member of the transforming growth factor-β superfamily of cytokines, decrease with age in mice, and that restoring the level of GDF11 decreases aging-associated cardiac phenotypes, including cardiac hypertrophy.90 Although the age-dependent decrease in GDF11 and its effect on aging-induced cardiac hypertrophy could not be reproduced in another report,91 the antisenescence effect of GDF11 was also observed in skeletal muscles.92 Furthermore, systemic supplementation of GDF11 was shown to increase the LC3-II/LC3-I ratio in skeletal muscle. However, whether GDF11 increases autophagic flux or whether autophagy plays a causative role in mediating the antisenescence effect of GDF11 was not tested in this study.

Taken together, these studies show that the list of potential mechanisms controlling senescence of the organism as a whole and of individual organs such as the heart is growing. According to the hormesis hypothesis, the accumulation of molecular mechanisms conferring stress resistance may prevent senescence of organisms. Thus, it would be interesting to investigate whether the aforementioned mechanisms controlling senescence protect the heart against stress and inhibit accumulation of damage in the heart. Interestingly, as described below, these mechanisms generally affect autophagy.

Role of Autophagy During Aging of the Heart

Damage to proteins, DNA, and cellular organelles plays an important role in aging.93 Accumulation of damaged proteins and organelles leads to the age-associated malfunction of many biological processes. Thus, reduced degradation of proteins and organelles may contribute to the aging process.29 In cardiomyocytes, the accumulation of dysfunctional organelles and toxic proteins results in global cardiac dysfunction. Because autophagy plays a crucial role in the degradation of long-lived proteins and organelles, it is an essential mechanism for maintenance of tissue homeostasis in the heart during the aging process.15,16,94 Three types of autophagy have been identified: microautophagy, chaperone-mediated autophagy (CMA), and macroautophagy. In microautophagy, cytoplasmic cargo is directly trapped and engulfed through membrane invagination by lysosomes. Although it is thought to be a random process, recent evidence suggests that parts of mitochondria are also degraded through this mechanism.95 CMA, on the contrary, specifically degrades cytosolic proteins with a KFERQ motif, by directly transferring them to lysosomes. In macroautophagy, hereafter referred to as autophagy, small vesicular sacs, called isolation membranes or phagophores, are initially formed. The phagophores enclose cytosolic long-lived proteins and organelles, resulting in the formation of double-membrane structures called autophagosomes. The autophagosomes then fuse with lysosomes, which leads to the degradation of the sequestered cellular contents through digestion of the cargo by lysosomal hydrolases.15,16,94 Essentially nothing is known about the role of microautophagy and CMA during aging in the heart. Thus, we focus on macroautophagy in the discussion below.

Autophagy Is Downregulated During the Course of Aging

Autophagy is downregulated in the heart during the course of aging.96 The general mechanisms of aging described above may also contribute to this downregulation of autophagy (Figure 1). Seemingly paradoxically, although ROS and misfolded proteins can stimulate autophagy, suppression of autophagy is commonly observed in aging hearts with increased oxidative stress, misfolded proteins, and dysfunctional mitochondria. One possible explanation for this apparent paradox is that continuous activation of autophagy caused by higher oxidative stress and protein misfolding may lead to exhaustion of the autophagic machinery, eventually causing suppression of autophagy. A similar phenomenon, termed autophagy exhaustion, was reported to have been observed after HIV-1 infection.97 Aging is also characterized by attenuation of stress-induced adaptations, which may result, in part, from the suppression of autophagy. In particular, activation of autophagy is required to potentiate the protective effect of ischemic preconditioning,98 raising the possibility that autophagy exhaustion may contribute to the increased susceptibility of elderly patients to myocardial ischemia. Whether autophagy exhaustion actually takes place in aging hearts remains to be tested.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Regulation of cardiac aging by autophagy. Aging inhibits autophagy in cardiomyocytes through multiple mechanisms. Aging-induced suppression of autophagy induces accumulation of misfolded proteins and dysfunctional organelles, sterile infection caused by undigested mitochondrial DNA, inflammation, and lipotoxicity, thereby leading to a metabolically unhealthier environment, precipitous mitochondrial dysfunction and eventual cell death. FoxO indicates forkhead box O; mTOR, mammalian target of rapamycin; ROS, reactive oxygen species; and UPR, unfolded protein response.

Activation of major suppressors of autophagy, such as Mst199 and mTOR,100 or suppression of major activators of autophagy, such as Sirt1,77 may also cause downregulation of autophagy in the heart. Further experimentation is required to test these hypotheses.

In addition, a variety of other mechanisms have been shown to contribute to the age-dependent downregulation of autophagy. The genes involved in general and mitochondria-specific autophagy are regulated by transcription factors, including FoxO, HIF-1 (hypoxia inducible factor-1), p53, E2F1 (E2F transcription factor 1), NF-κB, KLF4 (Kruppel-like factor 4), TFEB (transcription factor EB), and ZKSCAN3 (zinc finger with KRAB and SCAN domains 3).77,101,102 The transcriptional activity of FoxO is negatively regulated by Akt-mediated phosphorylation and by lysine acetylation resulting from decreases in NAD+ and consequent inactivation of Sirt1 in the heart. This, in turn, may contribute to decreased expression of autophagy-related genes in the aged heart. Aging has also been shown to upregulate miR-216a, which, in turn, downregulates Beclin1, thereby inhibiting oxidized low-density lipoprotein–induced stimulation of autophagy in endothelial cells.103 In contrast, atrogin-1, an E3 uibiquitin ligase known to be activated in response to muscle atrophy, induces autophagy through degradation of charged multivesicular body protein 2B, a component of the endosomal sorting protein complex that is essential for autophagy.104 However, although the activity of the ubiquitin proteasome system declines with aging, whether atrogin-1 is downregulated in aging hearts is unknown. Finally, saturated and unsaturated fatty acids induce metabolomic profiles that differentially affect aging through the activation of distinct forms of autophagy in the liver: the former activates PIK3C3- and Beclin1-dependent autophagy by depleting autophagy-inhibitory amino acids, whereas the latter activates PIK3C3- and Beclin1-independent autophagy by increasing the level of NAD+. Whereas the effects of saturated fatty acids on health are detrimental, those of unsaturated fatty acids are beneficial.105 However, how the metabolic perturbation observed in age-associated heart disease affects metabolomic profiles and autophagy remains to be elucidated.

Autophagy Is Essential for Preventing Aging in the Heart

Increasing lines of evidence suggest that autophagy is intimately involved in the regulation of lifespan and aging.21 Loss-of-function mutations in autophagy-related genes, Atg1, Atg7, Atg18, and Beclin1, key autophagy genes, decrease the lifespan of the nematode C. elegans.106 Similarly, in a genetic screen of budding yeast, several short-lived mutants had autophagy defects, including 10 ATG mutations found among a total of 117 short-lived mutants.107 Deficient expression of Atg1 facilitates accumulation of ROS and muscle degeneration, mimicking the aging phenotype, in the fruit fly Drosophila melanogaster.108 Mutations in Atg8 also induce accumulation of insoluble proteins, increase sensitivity to ROS, and shorten lifespan in Drosophila, whereas increased expression of Atg8 in the nervous system of Drosophila extends its lifespan.109 Autophagy-related genes have also been shown to promote survival in worms and flies exposed to prolonged starvation,110 by alleviating age-associated pathologies, including mitochondrial and cardiac dysfunction.108

In mammals, tissue-specific knockout of ATG genes induces multiple age-associated symptoms, including accumulation of intracellular inclusion bodies containing ubiquitinylated proteins, accumulation of lysosomes containing lipofuscin, disorganized mitochondria, and protein oxidation.111–115 In contrast, adenovirus-directed overexpression of Atg7 that corrected a hepatic autophagic defect was shown to diminish ER stress and counteract insulin resistance.115 Stimulation of autophagy reduces oncogenesis, maintains neuronal function,116 improves immune responses,117 reduces inflammation,118 and improves lipid mobilization119 in the organism as a whole, thereby improving overall fitness during aging.16,21 However, more studies may be needed to clarify whether the lifespan of mice can be prolonged by selectively correcting aging-associated defects in autophagy.

Autophagy may be especially important in nonproliferating cells because there is no dilution of toxic materials accumulated during aging through cell division. In terms of cardiac aging, mice in which the Atg5 protein is cardiac-specifically deleted through constitutive αMHC-Cre expression develop dilated cardiomyopathy with severe systolic dysfunction during aging, accompanied by sarcomeric disarray and accumulation of dysfunctional and abnormal mitochondria.96 Cardiac-specific deletion of glycogen synthase kinase (GSK)-3α also promoted the development of cardiac aging, and this was accompanied by the suppression of autophagy.120 One cautionary note is that the use of αMHC-Cre, originally generated by Dr Michael Schneider’s laboratory for the use in aging studies, may potentially be problematic because cardiac-specific Cre alone induces significant time-dependent cardiac dysfunction.121 Nevertheless, these results strongly suggest that autophagy is required for cardiac homeostasis during aging and that downregulation of autophagy contributes to cardiac pathology during aging. Indeed, a genome-wide association study of aging identified a single nucleotide polymorphism near the Atg4c gene as being associated with a higher risk of death, suggesting that autophagy may be intimately involved in the risk of heart disease in elderly patients.122 Furthermore, autophagy also alleviates accumulation of advanced glycation end products123 and preamyloid oligomers.124 However, determining whether downregulation of autophagy mechanistically contributes to the development of cardiac aging awaits further experimentation to test whether restoring the level of autophagy rescues the aging phenotype.

The lysosome-associated membrane protein 2a, a protein required for CMA, is also downregulated during the aging process in the mouse liver.125 Restoration of lysosome-associated membrane protein 2a prevents aging-associated defects in CMA and decreases the abundance of oxidized proteins, polyubiquitinated protein aggregates, and apoptotic cells in the liver.125 The role of CMA in cardiac aging remains to be elucidated.

Role of Mitophagy

Damaged mitochondria can be eliminated through a specialized form of autophagy termed mitophagy or mitochondrial autophagy. Autophagosomes containing only mitochondria have been observed in electron microscopic analyses of the hearts of adult mice, providing evidence for the existence of mitophagy in the heart.126 The molecular mechanisms mediating mitochondrial autophagy and its functional significance in the heart have been reviewed recently.127 In perhaps the most well-characterized mechanism of mitochondrial autophagy, depolarized mitochondria are marked by a PTEN-induced putative kinase 1 (PINK1)-Parkin-mitofusin 2 (Mfn2)–dependent mechanism and engulfed by autophagosomes through an LC3-receptor–dependent mechanism.128 A recent report showed that PINK1-induced phosphorylation of ubiquitin recruits LC3 receptor proteins, including NDP52 and optineurin, which in turn recruit the autophagy factors, including Ulk1, DFCP1 (double FYVE domain–containing protein 1), and WIPI1 (WD repeat domain, phosphoinositide interacting 1), to mitochondria.129 However, more investigation is needed to fully elucidate how depolarized mitochondria are marked and recognized by LC3 and the involvement of Parkin-Mfn2 in this process. On the contrary, increasing lines of evidence suggest that mitochondrial autophagy can take place in a Parkin-independent manner130 or even in the absence of Atg5/7,131 suggesting that there are multiple mechanisms by which mitochondria may be degraded, perhaps in a stimulus-dependent fashion. In addition, mitochondria can be degraded by microautophagy and mitochondria-derived vesicles.61 Given that mitochondrial dysfunction can develop with aging and that mitochondria are the major source of ROS in aging hearts, it is critically important to understand how mitochondrial autophagy is regulated in aging hearts (Figure 2).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Mechanisms of mitochondrial autophagy in the heart. Molecular mechanisms mediating mitochondrial degradation are summarized. The contribution of each mechanism to the regulation of cardiac senescence at baseline and under stress remains to be elucidated. Mfn2 indicates mitofusin 2; Pink1, PTEN-induced putative kinase 1; and UPS, ubiquitin proteasome system.

It should be noted that there have been no studies quantitatively evaluating the changes in mitophagy during cardiac aging to date. Because mitochondrial dysfunction is a common feature of cardiac aging, in theory, more mitophagy and mitochondrial autophagy should be observed, at least in the early phase of aging. In C. elegans, age-associated stress such as oxidative stress stimulates both mitochondrial biogenesis and mitophagy through SKN-1 (skinhead-1), a homolog of Nrf2 (nuclear factor [erythroid-derived 2]-like 2), thereby coordinating mitochondrial turnover.132 As noted above, to date, most studies of mitophagy in the heart have focused on PINK1-Parkin–mediated mitophagy. One study showed that although young Parkin knockout mice exhibit a normal cardiac phenotype, abnormal mitochondria accumulate in cardiomyocytes with age in these mice.133 This suggests that endogenous Parkin may mediate mitophagy in aging hearts. It is unclear, however, how Parkin expression is regulated during aging. Furthermore, considering the fact that Parkin has multiple functions besides mitophagy,134 whether downregulation of Parkin directly promotes accumulation of abnormal mitochondria through a defect in mitophagy remains to be tested. Damaged mitochondria can be eliminated by multiple mechanisms, including mitochondrial proteases, ubiquitin proteasome-dependent mechanisms, Parkin-independent macroautophagy, a nonconventional form of autophagy, microautophagy, and mitochondria-derived vesicles.61 Currently, how these mechanisms are affected by cardiac aging is unknown. In erythroid cells in which mtDNA mutation is stimulated, mitochondrial autophagy is downregulated by aging.67 Accumulation of damaged mtDNA activates mTOR, which inhibits autophagy, thereby preventing elimination of mitochondria containing damaged mtDNA and initiating a feed-forward mechanism that causes rapid accumulation of dysfunctional mitochondria and cell death. It will be interesting to test whether similar mechanisms exist in aging hearts.

Mito-Timer is a time-sensitive fluorescent protein targeted to the mitochondrial matrix that can be used to evaluate mitochondrial age by quantifying the proportionate integration of young (green) and old (red) Mito-Timer protein.135 Transgenic mice with cardiac-specific expression of Mito-Timer have recently been developed.136 These mice should be useful for evaluating age-dependent changes in mitochondrial turnover. Age-associated deterioration in the mitochondrial quality control mechanisms, including decreases in mitophagy, may be indicated by a slower mitochondrial turnover rate in this animal model.

Relevant Intracellular Signaling Mechanisms Controlling Autophagy During Aging

Sirtuins

Yeast silent information regulator 2 (Sir2) is an evolutionarily conserved molecule that mediates lifespan extension in yeast and Drosophila in response to CR.137–139 Sir2 is an NAD+-dependent protein deacetylase and functions in a wide array of cellular processes, including gene silencing, rDNA recombination, lifespan extension, and DNA damage repair.140,141 Overexpression of Sir2 increases the lifespan of many organisms, including yeast, C. elegans and Drosophila.138,142 Recently, the concept that lifespan extension in terminally differentiated cells might depend on mechanisms similar to those that regulate chronological lifespan in yeast has been challenged.143 Nonetheless, we have shown that Sirt1, a mammalian ortholog of Sir2, is able to retard aging of the heart, an organ whose major component is terminally differentiated cardiomyocytes.140 Sirt1 deacetylates p53 and the FoxO family transcription factors, thereby inhibiting apoptotic cell death in mice and humans.144–149 Mice deficient in Sirt1 exhibit developmental abnormality in the heart and only infrequently survive postnatally.150 Sirt1 is upregulated by CR and regulates fat metabolism by inhibiting fat cell differentiation and fat accumulation through regulation of peroxisome proliferator-activated receptor-γ.151 Three- to 6-fold overexpression of Sirt1 attenuates aging-induced cardiac pathology, including hypertrophy, fibrosis, apoptosis, and upregulation of senescence markers, and protects the heart against oxidative stress.75 Furthermore, endogenous Sirt1 protects the heart against ischemia/reperfusion injury, in part, through deacetylation of FoxO1 and consequent upregulation of antioxidants.152 Sirt1 also mediates fasting-induced deacetylation of FoxO1 in the heart, thereby stimulating autophagosome formation and autophagosome–lysosome fusion through transcriptional upregulation of Rab7 in cardiomyocytes.77 Sirt3 mediates the effect of CR on age-related hearing loss and oxidative stress in mice.153,154 Given that their functions favor longevity and cell survival, and that they are coupled with the metabolic state of cells and with autophagy, both Sirt1 and Sirt3 are attractive candidates for critically regulating cell survival in cardiomyocytes in response to stresses such as energy starvation.

NAD+ and Protein Acetylation

NAD+ is an electron acceptor in the mitochondrial electron transport chain and also acts as an essential substrate for NAD+-dependent enzymes, including sirtuins and poly ADP ribose polymerase, a DNA repair enzyme. Cellular levels of NAD+ are regulated by the balance between synthesis through the de novo and salvage pathways and consumption through sirtuins and poly ADP ribose polymerase. NAD+ in turn regulates the level of protein acetylation through regulation of sirtuins.155 We have shown previously that nicotinamide phosphoribosyl transferase (Nampt), a key enzyme in the salvage pathway of NAD+ synthesis in cardiomyocytes, is downregulated in the heart in response to prolonged ischemia, which leads to decreases in the level of NAD+ in the heart, inhibition of autophagic flux, and consequent increases in cell death.156 However, restoration of the NAD+ level by overexpressing Nampt restores the level of autophagy during prolonged ischemia and reduces the extent of myocardial infarction.156 Autophagic flux is negatively affected by decreases in NAD+ during ischemia due to resultant decreases in lysosomal acidification. We hypothesize that maintaining the NAD+ level is essential for maintaining the activity of the H+ pump on the lysosomal membrane.157 Decreases in NAD+ also increase protein acetylation through suppression of sirtuins, which in turn suppresses autophagy.

The level of NAD+ decreases with age in many organs, because of downregulation of Nampt, defective circadian rhythm, oxidative stress, and accumulation of DNA damage.155 Although the level of Nampt in the mouse heart is upregulated at 1 year of age, whether it is downregulated thereafter has not been shown. We speculate that, as in the case of prolonged ischemia, aging-induced decreases in NAD+ may induce lysosomal dysfunction, which in turn contributes to age-dependent increases in the susceptibility of the heart to ischemic injury. In the rate-limiting step of the salvage pathway of NAD+ synthesis, Nampt produces nicotinamide mononucleotide, which is then converted to NAD+. Exogenous supplementation of nicotinamide mononucleotide increases NAD+ content in cardiomyocytes, stimulating Sirt1 and inducing deacetylation of cellular proteins, including FoxO, in the heart, which, in turn, protects the heart from ischemia/reperfusion injury.158 This suggests that supplementation of NAD+ via its precursors, including nicotinamide mononucleotide and nicotinamide riboside, may allow suppression of cardiac aging through the activation of sirtuins, including Sirt1 and Sirt3, increases in protein deacetylation in the nucleus and mitochondria, and activation of autophagy.

Insulin-Like Growth Factor I Signaling

In lower organisms, inhibition of insulin-like growth factor (IGF-I) signaling, such as by Daf2 mutation in C. elegans, causes lifespan extension.159 This is mediated by a loss of suppression of Daf16 or FoxO transcription factors, which regulate expression of antioxidants (MnSOD) and DNA damage repair enzymes (GADD45).160–163 In mammals, Ames and Snell dwarf mice lacking growth hormone/IGF-I signaling and IGF-I receptor heterozygous knockout mice have longer lifespans.164,165 Systemic overexpression of klotho, a hormone known to inhibit insulin/IGF-I signaling, also extends lifespan in mice.166 It should be noted, however, that whether inhibiting IGF-I signaling (and thus stimulating FoxOs) positively affects senescence and aging-related diseases in mammals without affecting normal function is not fully understood.167 IGF-I may only produce a trade-off between current benefits to reproduction and later costs in senescence, like the relationship between inotropic agents and exacerbation of heart failure.168 Interestingly, activation of Akt weakens cardiac adaptation to stress169 and exacerbates the aging phenotype in the heart, effects that are accompanied by suppression of autophagy.170 However, the specific role of Akt in cardiac aging and how autophagy affects this process are not yet known. Considering the apparent cell survival–promoting effects of the IGF-I-Akt axis, this issue seems to represent a paradox in longevity research and will require clarification in each organ.165

GSK-3, AMP-Activated Protein Kinase, and mTOR

mTOR inhibits autophagy through phosphorylation of Ulk1, a mammalian ortholog of Atg1, at Ser 757.87 Conversely, suppression of mTORC1 by rapamycin stimulates autophagy in cardiomyocytes.100,171 Although inhibition of mTORC1 by rapamycin has been shown to attenuate the adverse effects of aging in the heart,172 whether the effect of mTORC1 suppression is mediated through stimulation of autophagy awaits further investigation using more specific interventions to control autophagy because mTORC1 has a wide variety of cellular functions besides suppression of autophagy.86 The activity of mTOR is regulated by multiple mechanisms.86 However, negative regulation by GSK-3β and AMP-activated protein kinase (AMPK) is particularly relevant with regards to aging and autophagy.

We have shown that GSK-3β stimulates autophagy through the suppression of mTOR in cardiomyocytes.173 In addition, cardiac-specific GSK-3α knockout mice show significantly shorter lifespans and exacerbated cardiac aging caused by the suppression of autophagy.174 Although it is currently unclear how the activities of GSK-3α and GSK-3β are regulated during the course of aging, they have been shown to be intimately involved in the growth and death of cardiomyocytes, mitochondrial permeability transition pore opening, and regulation of mTOR signaling.175 Thus, further investigation is required to elucidate the roles of GSK-3α and GSK-3β in regulating cardiac aging and autophagy signaling.

Likewise, AMPK stimulates autophagy through the suppression of mTORC1 and phosphorylation of Ulk1.87,176 Metformin, an activator of AMPK, has been shown to increase lifespan in mice.177 In addition, metformin also attenuates aging-induced cardiomyocyte contractile defects.178 It would be interesting to investigate to what extent stimulation of autophagy contributes to the salutary effect of metformin.

Oxidative Stress

Oxidative stress can either activate or inactivate autophagy in cardiomyocytes in a context-dependent manner.179 We have shown previously that oxidative stress during ischemia/reperfusion in the heart stimulates autophagy by upregulating Beclin1.180 In addition, glucose deprivation and hypoxia activate autophagy through the upregulation of Nox4 in the ER and consequent activation of PERK-dependent mechanisms.181 Although increases in oxidative stress induce tissue damage, mitochondrial dysfunction and cell death, whether age-dependent increases in oxidative stress suppress autophagy in the heart has not yet been clearly demonstrated.

How to Stimulate Autophagy

Because autophagy is downregulated with age and downregulation of autophagy promotes senescence of the heart, interventions to increase the level of autophagy may prevent or slow the progression of aging in the heart. Furthermore, considering the fact that cardiac aging is accompanied by the accumulation of insoluble polymeric materials, such as lipofuscin, and damaged organelles, it would seem to be advantageous to have a degradation mechanism with a large capacity (Figure 3).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Possible interventions to normalize autophagy during cardiac aging. Aging inhibits autophagy and mitophagy in cardiomyocytes. Interventions to normalize autophagy and mitophagy and to alleviate protein aggregates may attenuate aging of the heart and increase the resistance of the heart stress. mTOR indicates mammalian target of rapamycin; and NMN, nicotinamide mononucleotide.

Interestingly, both CR139,182–185 and suppression of mTOR,88,186,187 interventions that alleviate the adverse effects of aging and increase lifespan, promote autophagy in many cell types and organs, even when autophagy is suppressed by aging. Importantly, CR has been shown to reduce age-related pathologies and diseases in animals.188–190 However, whether the beneficial effects of these interventions are mediated primarily through activation of autophagy in the heart requires further study.

Voluntary exercise activates autophagy by stimulating phosphorylation of Bcl-2 and its dissociation from Beclin1.191 Exercise leads to a reduction in protein aggregates in the heart, which is accompanied by increases in autophagic flux, but not in the ubiquitin proteasome system or UPR.192 We speculate that the antisenescence effect of exercise on the heart192 may be, in part, mediated through the activation of autophagy and consequent amelioration of protein aggregate formation.

Toll-interacting proteins interact with LC3 and ubiquitin, thereby binding to ubiquitin conjugates more tightly than p62 and effectively clearing highly aggregation-prone proteins such as Huntington poly-glutamine protein.193 Thus, an intervention that upregulates them in vivo might be effective in clearing protein aggregates associated with aging, such as preamyloid bodies and lipofuscin. A recent report shows, however, that Toll-interacting protein promotes inflammation and apoptosis in the heart after myocardial infarction.194 Thus, further investigation is needed to clarify the function of this protein in the heart.

Trehalose is a naturally occurring disaccharide that is induced in response to dehydration in plants and promotes their survival by inducing autophagy, thus fulfilling the definition of a hormetic response.195 We have shown recently that trehalose treatment increases autophagy in the mouse heart and the cardiomyocytes therein.196 It will be interesting to test whether trehalose also inhibits the adverse effects of aging in the heart by stimulating autophagy.

It should be noted that the interventions discussed above have multiple effects in the heart besides autophagy. Furthermore, their effects may be mediated through noncardiac cells. For example, growth factors, miRNA, and exosomes excreted from distal organs may mediate autophagy and inhibit senescence in the heart after reaching the heart through the systemic circulation.197 Thus, where such is likely to be the case for a particular antisenescence intervention, further investigation is needed to identify the responsible cell type and the mechanism of transmission.

Concluding Remarks

Accumulating lines of evidence suggest that the ability of cardiomyocytes to maintain appropriate levels of autophagy may decline during aging of the heart. However, many questions remain unanswered. First, it is unclear when the level of autophagy becomes significantly altered during the course of aging in the human heart. Currently, evaluating the level of autophagy and autophagic flux is challenging in the human heart in vivo. Developing convenient and reliable methods to accurately evaluate cardiac autophagy is essential. Second, more investigation is needed to elucidate the molecular mechanism by which autophagy or mitochondrial autophagy is regulated during the course of aging in the heart. Autophagy is regulated not only at the level of autophagosome formation but also at the levels of autophagosome–lysosome fusion and lysosomal degradation. In particular, how the function of lysosomes is affected by aging requires further investigation. Third, more investigation is needed to clarify the functional role of autophagy or mitophagy during cardiac aging. Currently, none of the available molecular interventions allow purely specific modification of either autophagy or mitophagy in mammalian cells. Whether protein aggregates, such as accumulated lipofuscin, are causatively involved in cardiac aging has not been formally addressed. Development of a more selective intervention or improvement of the selectivity by combining multiple interventions seems essential. Fourth, it is important to clarify the molecular mechanisms by which autophagy or mitophagy regulates cardiac aging. Although autophagy is generally thought to be a nonspecific mechanism of protein degradation, there is increasing evidence that some proteins may be specifically degraded through their association with LC3 receptor proteins.198 Identification of specific targets of autophagy during aging may allow a better understanding of the molecular mechanisms of cardiac aging. Fifth, most of the investigations reported to date focused only on autophagy in cardiomyocytes during aging. It is important to determine whether autophagy in other cell types, such as inflammatory cells, also affects cardiac aging and, if so, how these cells communicate with cardiomyocytes, such as through secretion of paracrine factors, circulating miRNA, or exosomes. Likewise, a better understanding of the function of autophagy in cardiac progenitor cells is also highly relevant for aging research in the heart. Finally, it is essential to develop more convenient and specific interventions to normalize the level of autophagy in the heart during aging.

Autophagy mediates many lifespan-extending and antisenescence mechanisms.21 In particular, considering the emerging importance of the UPRmt as a fundamental mechanism of longevity enhancement, elucidating the connection between the UPRmt and autophagy/mitophagy is of great interest.199 Together with the recent advancement in understanding the molecular mechanisms of autophagy, investigating the role of autophagy/mitophagy during cardiac aging should eventually lead to the development of more efficient and specific interventions to slow senescence and increase stress resistance in the heart.

Acknowledgments

The authors thank Christopher D. Brady for critical reading of the article.

Sources of Funding

This work was supported, in part, by US Public Health Service Grants HL67724, HL91469, HL102738, HL112330, and AG23039 and by the Leducq Foundation Transatlantic Network of Excellence (Dr Sadoshima). A. Shirakabe has been supported by a Postdoctoral Fellowship from the Uehara Memorial Foundation.

Disclosures

None.

Footnotes

  • This Review is in a thematic series on Aging and the Cardiovascular System, which includes the following articles:

    Mechanical Regulation of Cardiac Aging in Model Systems

    Aging and Autophagy in the Heart

    Macromolecular Degradation Systems and Cardiovascular Aging

    Mitochondrial Metabolism in Aging Heart

    Dietary Interventions, Cardiovascular Aging, and Disease: Animal Models and Human Studies

    Pharmacological Strategies to Retard Cardiovascular Aging

    Guest Editors: Guido Kroemer and Lorenzo Galluzzi

  • Nonstandard Abbreviations and Acronyms
    Atg
    autophagy-related genes
    CMA
    chaperone-mediated autophagy
    CR
    caloric restriction
    ER
    endoplasmic reticulum
    FoxO
    Forkhead box O
    IGF-I
    insulin-like growth factor I
    mtDNA
    mitochondrial DNA
    mTOR
    mammalian target of rapamycin
    mTORC1
    mTOR complex 1
    NAD+
    nicotinamide adenine dinucleotide
    Nampt
    nicotinamide phosphoribosyl transferase
    ROS
    reactive oxygen species
    UPRmt
    mitochondrial unfolded protein response

  • Received January 14, 2016.
  • Revision received February 9, 2016.
  • Accepted February 15, 2016.
  • © 2016 American Heart Association, Inc.

References

  1. 1.↵
    1. Mozaffarian D,
    2. Benjamin EJ,
    3. Go AS,
    4. et al.,
    5. American Heart Association Statistics Committee and Stroke Statistics Subcommittee
    . Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation. 2015;131:e29–322. doi: 10.1161/CIR.0000000000000152.
    OpenUrlFREE Full Text
  2. 2.↵
    1. Lutz W,
    2. Sanderson W,
    3. Scherbov S.
    The coming acceleration of global population ageing. Nature. 2008;451:716–719. doi: 10.1038/nature06516.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Newman AB,
    2. Arnold AM,
    3. Naydeck BL,
    4. Fried LP,
    5. Burke GL,
    6. Enright P,
    7. Gottdiener J,
    8. Hirsch C,
    9. O’Leary D,
    10. Tracy R,
    11. Cardiovascular Health Study Research Group
    . “Successful aging”: effect of subclinical cardiovascular disease. Arch Intern Med. 2003;163:2315–2322. doi: 10.1001/archinte.163.19.2315.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Lloyd-Jones D,
    2. Adams R,
    3. Carnethon M,
    4. et al.,
    5. American Heart Association Statistics Committee and Stroke Statistics Subcommittee
    . Heart disease and stroke statistics–2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:e21–181. doi: 10.1161/CIRCULATIONAHA.108.191261.
    OpenUrlFREE Full Text
  5. 5.↵
    1. Buchberger A,
    2. Bukau B,
    3. Sommer T.
    Protein quality control in the cytosol and the endoplasmic reticulum: brothers in arms. Mol Cell. 2010;40:238–252. doi: 10.1016/j.molcel.2010.10.001.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Denzel MS,
    2. Storm NJ,
    3. Gutschmidt A,
    4. Baddi R,
    5. Hinze Y,
    6. Jarosch E,
    7. Sommer T,
    8. Hoppe T,
    9. Antebi A.
    Hexosamine pathway metabolites enhance protein quality control and prolong life. Cell. 2014;156:1167–1178. doi: 10.1016/j.cell.2014.01.061.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Finkel T,
    2. Serrano M,
    3. Blasco MA.
    The common biology of cancer and ageing. Nature. 2007;448:767–774. doi: 10.1038/nature05985.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Harman D.
    The biologic clock: the mitochondria? J Am Geriatr Soc. 1972;20:145–147.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Harmon HJ,
    2. Nank S,
    3. Floyd RA.
    Age-dependent changes in rat brain mitochondria of synaptic and non-synaptic origins. Mech Ageing Dev. 1987;38:167–177.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Finkel T,
    2. Holbrook NJ.
    Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408:239–247. doi: 10.1038/35041687.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Dutta D,
    2. Calvani R,
    3. Bernabei R,
    4. Leeuwenburgh C,
    5. Marzetti E.
    Contribution of impaired mitochondrial autophagy to cardiac aging: mechanisms and therapeutic opportunities. Circ Res. 2012;110:1125–1138. doi: 10.1161/CIRCRESAHA.111.246108.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Lu T,
    2. Finkel T.
    Free radicals and senescence. Exp Cell Res. 2008;314:1918–1922. doi: 10.1016/j.yexcr.2008.01.011.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Bergmann O,
    2. Bhardwaj RD,
    3. Bernard S,
    4. Zdunek S,
    5. Barnabé-Heider F,
    6. Walsh S,
    7. Zupicich J,
    8. Alkass K,
    9. Buchholz BA,
    10. Druid H,
    11. Jovinge S,
    12. Frisén J.
    Evidence for cardiomyocyte renewal in humans. Science. 2009;324:98–102. doi: 10.1126/science.1164680.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Wang X,
    2. Su H,
    3. Ranek MJ.
    Protein quality control and degradation in cardiomyocytes. J Mol Cell Cardiol. 2008;45:11–27. doi: 10.1016/j.yjmcc.2008.03.025.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Levine B,
    2. Kroemer G.
    Autophagy in the pathogenesis of disease. Cell. 2008;132:27–42. doi: 10.1016/j.cell.2007.12.018.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Rubinsztein DC,
    2. Mariño G,
    3. Kroemer G.
    Autophagy and aging. Cell. 2011;146:682–695. doi: 10.1016/j.cell.2011.07.030.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Wang K,
    2. Klionsky DJ.
    Mitochondria removal by autophagy. Autophagy. 2011;7:297–300.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Sciarretta S,
    2. Zhai P,
    3. Volpe M,
    4. Sadoshima J.
    Pharmacological modulation of autophagy during cardiac stress. J Cardiovasc Pharmacol. 2012;60:235–241. doi: 10.1097/FJC.0b013e3182575f61.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Youle RJ,
    2. van der Bliek AM.
    Mitochondrial fission, fusion, and stress. Science. 2012;337:1062–1065. doi: 10.1126/science.1219855.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Seo AY,
    2. Joseph AM,
    3. Dutta D,
    4. Hwang JC,
    5. Aris JP,
    6. Leeuwenburgh C.
    New insights into the role of mitochondria in aging: mitochondrial dynamics and more. J Cell Sci. 2010;123:2533–2542. doi: 10.1242/jcs.070490.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Madeo F,
    2. Zimmermann A,
    3. Maiuri MC,
    4. Kroemer G.
    Essential role for autophagy in life span extension. J Clin Invest. 2015;125:85–93. doi: 10.1172/JCI73946.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Sussman MA,
    2. Anversa P.
    Myocardial aging and senescence: where have the stem cells gone? Annu Rev Physiol. 2004;66:29–48. doi: 10.1146/annurev.physiol.66.032102.140723.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Lakatta EG.
    Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation. 2003;107:490–497.
    OpenUrlFREE Full Text
  24. 24.↵
    1. Lakatta EG,
    2. Levy D.
    Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a “set up” for vascular disease. Circulation. 2003;107:139–146.
    OpenUrlFREE Full Text
  25. 25.↵
    1. Lakatta EG,
    2. Levy D.
    Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation. 2003;107:346–354.
    OpenUrlFREE Full Text
  26. 26.↵
    1. Kajstura J,
    2. Cheng W,
    3. Sarangarajan R,
    4. Li P,
    5. Li B,
    6. Nitahara JA,
    7. Chapnick S,
    8. Reiss K,
    9. Olivetti G,
    10. Anversa P.
    Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats. Am J Physiol. 1996;271:H1215–H1228.
    OpenUrl
  27. 27.↵
    1. Swynghedauw B,
    2. Besse S,
    3. Assayag P,
    4. Carré F,
    5. Chevalier B,
    6. Charlemagne D,
    7. Delcayre C,
    8. Hardouin S,
    9. Heymes C,
    10. Moalic JM.
    Molecular and cellular biology of the senescent hypertrophied and failing heart. Am J Cardiol. 1995;76:2D–7D.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Olivetti G,
    2. Melissari M,
    3. Balbi T,
    4. Quaini F,
    5. Sonnenblick EH,
    6. Anversa P.
    Myocyte nuclear and possible cellular hyperplasia contribute to ventricular remodeling in the hypertrophic senescent heart in humans. J Am Coll Cardiol. 1994;24:140–149.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Cuervo AM,
    2. Bergamini E,
    3. Brunk UT,
    4. Dröge W,
    5. Ffrench M,
    6. Terman A.
    Autophagy and aging: the importance of maintaining “clean” cells. Autophagy. 2005;1:131–140.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Krishnamurthy J,
    2. Torrice C,
    3. Ramsey MR,
    4. Kovalev GI,
    5. Al-Regaiey K,
    6. Su L,
    7. Sharpless NE.
    Ink4a/Arf expression is a biomarker of aging. J Clin Invest. 2004;114:1299–1307. doi: 10.1172/JCI22475.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Satyanarayana A,
    2. Rudolph KL.
    p16 and ARF: activation of teenage proteins in old age. J Clin Invest. 2004;114:1237–1240. doi: 10.1172/JCI23437.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Kajstura J,
    2. Pertoldi B,
    3. Leri A,
    4. Beltrami CA,
    5. Deptala A,
    6. Darzynkiewicz Z,
    7. Anversa P.
    Telomere shortening is an in vivo marker of myocyte replication and aging. Am J Pathol. 2000;156:813–819. doi: 10.1016/S0002-9440(10)64949-8.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Takahashi T,
    2. Schunkert H,
    3. Isoyama S,
    4. Wei JY,
    5. Nadal-Ginard B,
    6. Grossman W,
    7. Izumo S.
    Age-related differences in the expression of proto-oncogene and contractile protein genes in response to pressure overload in the rat myocardium. J Clin Invest. 1992;89:939–946. doi: 10.1172/JCI115675.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Nadal-Ginard B,
    2. Kajstura J,
    3. Leri A,
    4. Anversa P.
    Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res. 2003;92:139–150.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Levine TB,
    2. Levine AB,
    3. Bolenbaugh J,
    4. Green PR.
    Reversal of heart failure remodeling with age. Am J Geriatr Cardiol. 2002;11:299–304.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Capasso JM,
    2. Palackal T,
    3. Olivetti G,
    4. Anversa P.
    Severe myocardial dysfunction induced by ventricular remodeling in aging rat hearts. Am J Physiol. 1990;259:H1086–H1096.
    OpenUrl
  37. 37.↵
    1. Mariani J,
    2. Ou R,
    3. Bailey M,
    4. Rowland M,
    5. Nagley P,
    6. Rosenfeldt F,
    7. Pepe S.
    Tolerance to ischemia and hypoxia is reduced in aged human myocardium. J Thorac Cardiovasc Surg. 2000;120:660–667. doi: 10.1067/mtc.2000.106528.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Edwards MG,
    2. Sarkar D,
    3. Klopp R,
    4. Morrow JD,
    5. Weindruch R,
    6. Prolla TA.
    Impairment of the transcriptional responses to oxidative stress in the heart of aged C57BL/6 mice. Ann N Y Acad Sci. 2004;1019:85–95. doi: 10.1196/annals.1297.017.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Zhang J,
    2. Bai Y,
    3. Huang L,
    4. Qi Y,
    5. Zhang Q,
    6. Li S,
    7. Wu Y,
    8. Li X.
    Protective effect of autophagy on human retinal pigment epithelial cells against lipofuscin fluorophore A2E: implications for age-related macular degeneration. Cell Death Dis. 2015;6:e1972. doi: 10.1038/cddis.2015.330.
    OpenUrlCrossRefPubMed
  40. 40.↵
    1. Finch CE,
    2. Ruvkun G.
    The genetics of aging. Annu Rev Genomics Hum Genet. 2001;2:435–462. doi: 10.1146/annurev.genom.2.1.435.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Martin FM,
    2. Friedman JS.
    Ticking fast or ticking slow, through Shc must you go? Sci Aging Knowledge Environ. 2004;2004:pe32. doi: 10.1126/sageke.2004.32.pe32.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    1. Tissenbaum HA,
    2. Guarente L.
    Model organisms as a guide to mammalian aging. Dev Cell. 2002;2:9–19.
    OpenUrlCrossRefPubMed
  43. 43.↵
    1. Quarrie JK,
    2. Riabowol KT.
    Murine models of life span extension. Sci Aging Knowledge Environ. 2004;2004:re5. doi: 10.1126/sageke.2004.31.re5.
    OpenUrlAbstract/FREE Full Text
  44. 44.↵
    1. Takahashi K,
    2. Takatsu M,
    3. Hattori T,
    4. Murase T,
    5. Ohura S,
    6. Takeshita Y,
    7. Watanabe S,
    8. Murohara T,
    9. Nagata K.
    Premature cardiac senescence in DahlS.Z-Lepr(fa)/Lepr(fa) rats as a new animal model of metabolic syndrome. Nagoya J Med Sci. 2014;76:35–49.
    OpenUrlPubMed
  45. 45.↵
    1. Boyd AC,
    2. Eshoo S,
    3. Richards DA,
    4. Thomas L.
    Hypertension accelerates the ‘normal’ aging process with a premature increase in left atrial volume. J Am Soc Hypertens. 2013;7:149–156. doi: 10.1016/j.jash.2012.12.008.
    OpenUrlCrossRefPubMed
  46. 46.↵
    1. Dai DF,
    2. Rabinovitch PS,
    3. Ungvari Z.
    Mitochondria and cardiovascular aging. Circ Res. 2012;110:1109–1124. doi: 10.1161/CIRCRESAHA.111.246140.
    OpenUrlAbstract/FREE Full Text
  47. 47.↵
    1. Mohamed SA,
    2. Hanke T,
    3. Erasmi AW,
    4. Bechtel MJ,
    5. Scharfschwerdt M,
    6. Meissner C,
    7. Sievers HH,
    8. Gosslau A.
    Mitochondrial DNA deletions and the aging heart. Exp Gerontol. 2006;41:508–517. doi: 10.1016/j.exger.2006.03.014.
    OpenUrlCrossRefPubMed
  48. 48.↵
    1. Veatch JR,
    2. McMurray MA,
    3. Nelson ZW,
    4. Gottschling DE.
    Mitochondrial dysfunction leads to nuclear genome instability via an iron-sulfur cluster defect. Cell. 2009;137:1247–1258. doi: 10.1016/j.cell.2009.04.014.
    OpenUrlCrossRefPubMed
  49. 49.↵
    1. Nunnari J,
    2. Suomalainen A.
    Mitochondria: in sickness and in health. Cell. 2012;148:1145–1159. doi: 10.1016/j.cell.2012.02.035.
    OpenUrlCrossRefPubMed
  50. 50.↵
    1. Chan DC.
    Mitochondria: dynamic organelles in disease, aging, and development. Cell. 2006;125:1241–1252. doi: 10.1016/j.cell.2006.06.010.
    OpenUrlCrossRefPubMed
  51. 51.↵
    1. Schriner SE,
    2. Linford NJ,
    3. Martin GM,
    4. Treuting P,
    5. Ogburn CE,
    6. Emond M,
    7. Coskun PE,
    8. Ladiges W,
    9. Wolf N,
    10. Van Remmen H,
    11. Wallace DC,
    12. Rabinovitch PS.
    Extension of murine life span by overexpression of catalase targeted to mitochondria. Science. 2005;308:1909–1911. doi: 10.1126/science.1106653.
    OpenUrlAbstract/FREE Full Text
  52. 52.↵
    1. Pérez VI,
    2. Bokov A,
    3. Van Remmen H,
    4. Mele J,
    5. Ran Q,
    6. Ikeno Y,
    7. Richardson A.
    Is the oxidative stress theory of aging dead? Biochim Biophys Acta. 2009;1790:1005–1014. doi: 10.1016/j.bbagen.2009.06.003.
    OpenUrlCrossRefPubMed
  53. 53.↵
    1. Ago T,
    2. Kuroda J,
    3. Pain J,
    4. Fu C,
    5. Li H,
    6. Sadoshima J.
    Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res. 2010;106:1253–1264. doi: 10.1161/CIRCRESAHA.109.213116.
    OpenUrlAbstract/FREE Full Text
  54. 54.↵
    1. Matsushima S,
    2. Kuroda J,
    3. Ago T,
    4. Zhai P,
    5. Park JY,
    6. Xie LH,
    7. Tian B,
    8. Sadoshima J.
    Increased oxidative stress in the nucleus caused by Nox4 mediates oxidation of HDAC4 and cardiac hypertrophy. Circ Res. 2013;112:651–663. doi: 10.1161/CIRCRESAHA.112.279760.
    OpenUrlAbstract/FREE Full Text
  55. 55.↵
    1. Kuroda J,
    2. Ago T,
    3. Matsushima S,
    4. Zhai P,
    5. Schneider MD,
    6. Sadoshima J.
    NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci U S A. 2010;107:15565–15570. doi: 10.1073/pnas.1002178107.
    OpenUrlAbstract/FREE Full Text
  56. 56.↵
    1. Zhang M,
    2. Brewer AC,
    3. Schröder K,
    4. Santos CX,
    5. Grieve DJ,
    6. Wang M,
    7. Anilkumar N,
    8. Yu B,
    9. Dong X,
    10. Walker SJ,
    11. Brandes RP,
    12. Shah AM.
    NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci U S A. 2010;107:18121–18126. doi: 10.1073/pnas.1009700107.
    OpenUrlAbstract/FREE Full Text
  57. 57.↵
    1. Sciarretta S,
    2. Zhai P,
    3. Volpe M,
    4. Sadoshima J.
    Activation of Nox4 promotes cardiomyocyte autophagy and survival during nutrient starvation. Circulation 2012;126:A18056.
    OpenUrl
  58. 58.↵
    1. Ago T,
    2. Sadoshima J.
    Thioredoxin1 as a negative regulator of cardiac hypertrophy. Antioxid Redox Signal. 2007;9:679–687. doi: 10.1089/ars.2007.1529.
    OpenUrlCrossRefPubMed
  59. 59.↵
    1. Ide T,
    2. Tsutsui H,
    3. Hayashidani S,
    4. Kang D,
    5. Suematsu N,
    6. Nakamura K,
    7. Utsumi H,
    8. Hamasaki N,
    9. Takeshita A.
    Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res. 2001;88:529–535.
    OpenUrlAbstract/FREE Full Text
  60. 60.↵
    1. Quirós PM,
    2. Langer T,
    3. López-Otín C.
    New roles for mitochondrial proteases in health, ageing and disease. Nat Rev Mol Cell Biol. 2015;16:345–359. doi: 10.1038/nrm3984.
    OpenUrlCrossRefPubMed
  61. 61.↵
    1. Sugiura A,
    2. McLelland GL,
    3. Fon EA,
    4. McBride HM.
    A new pathway for mitochondrial quality control: mitochondrial-derived vesicles. EMBO J. 2014;33:2142–2156. doi: 10.15252/embj.201488104.
    OpenUrlAbstract/FREE Full Text
  62. 62.↵
    1. Scott I,
    2. Webster BR,
    3. Chan CK,
    4. Okonkwo JU,
    5. Han K,
    6. Sack MN.
    GCN5-like protein 1 (GCN5L1) controls mitochondrial content through coordinated regulation of mitochondrial biogenesis and mitophagy. J Biol Chem. 2014;289:2864–2872. doi: 10.1074/jbc.M113.521641.
    OpenUrlAbstract/FREE Full Text
  63. 63.↵
    1. Jensen MB,
    2. Jasper H.
    Mitochondrial proteostasis in the control of aging and longevity. Cell Metab. 2014;20:214–225. doi: 10.1016/j.cmet.2014.05.006.
    OpenUrlCrossRefPubMed
  64. 64.↵
    1. Papa L,
    2. Germain D.
    SirT3 regulates the mitochondrial unfolded protein response. Mol Cell Biol. 2014;34:699–710. doi: 10.1128/MCB.01337-13.
    OpenUrlAbstract/FREE Full Text
  65. 65.↵
    1. Wang ZV,
    2. Hill JA.
    Protein quality control and metabolism: bidirectional control in the heart. Cell Metab. 2015;21:215–226. doi: 10.1016/j.cmet.2015.01.016.
    OpenUrlCrossRefPubMed
  66. 66.↵
    1. Aumailley L,
    2. Garand C,
    3. Dubois MJ,
    4. Johnson FB,
    5. Marette A,
    6. Lebel M.
    Metabolic and phenotypic differences between mice producing a werner syndrome helicase mutant protein and Wrn null mice. PLoS One. 2015;10:e0140292. doi: 10.1371/journal.pone.0140292.
    OpenUrlCrossRefPubMed
  67. 67.↵
    1. Li-Harms X,
    2. Milasta S,
    3. Lynch J,
    4. Wright C,
    5. Joshi A,
    6. Iyengar R,
    7. Neale G,
    8. Wang X,
    9. Wang YD,
    10. Prolla TA,
    11. Thompson JE,
    12. Opferman JT,
    13. Green DR,
    14. Schuetz J,
    15. Kundu M.
    Mito-protective autophagy is impaired in erythroid cells of aged mtDNA-mutator mice. Blood. 2015;125:162–174. doi: 10.1182/blood-2014-07-586396.
    OpenUrlAbstract/FREE Full Text
  68. 68.↵
    1. Gonzalez-Valdes I,
    2. Hidalgo I,
    3. Bujarrabal A,
    4. Lara-Pezzi E,
    5. Padron-Barthe L,
    6. Garcia-Pavia P,
    7. Gómez-del Arco P,
    8. Gomez P,
    9. Redondo JM,
    10. Ruiz-Cabello JM,
    11. Jimenez-Borreguero LJ,
    12. Enriquez JA,
    13. de la Pompa JL,
    14. Hidalgo A,
    15. Gonzalez S.
    Bmi1 limits dilated cardiomyopathy and heart failure by inhibiting cardiac senescence. Nat Commun. 2015;6:6473. doi: 10.1038/ncomms7473.
    OpenUrlCrossRefPubMed
  69. 69.↵
    1. Kang C,
    2. Xu Q,
    3. Martin TD,
    4. Li MZ,
    5. Demaria M,
    6. Aron L,
    7. Lu T,
    8. Yankner BA,
    9. Campisi J,
    10. Elledge SJ.
    The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. Science. 2015;349:aaa5612. doi: 10.1126/science.aaa5612.
    OpenUrlAbstract/FREE Full Text
  70. 70.↵
    1. Moslehi J,
    2. DePinho RA,
    3. Sahin E.
    Telomeres and mitochondria in the aging heart. Circ Res. 2012;110:1226–1237. doi: 10.1161/CIRCRESAHA.111.246868.
    OpenUrlAbstract/FREE Full Text
  71. 71.↵
    1. Hosoda T,
    2. Kajstura J,
    3. Leri A,
    4. Anversa P.
    Mechanisms of myocardial regeneration. Circ J. 2010;74:13–17.
    OpenUrlCrossRefPubMed
  72. 72.↵
    1. García-Prat L,
    2. Martínez-Vicente M,
    3. Perdiguero E,
    4. Ortet L,
    5. Rodríguez-Ubreva J,
    6. Rebollo E,
    7. Ruiz-Bonilla V,
    8. Gutarra S,
    9. Ballestar E,
    10. Serrano AL,
    11. Sandri M,
    12. Muñoz-Cánoves P.
    Autophagy maintains stemness by preventing senescence. Nature. 2016;529:37–42. doi: 10.1038/nature16187.
    OpenUrlCrossRefPubMed
  73. 73.↵
    1. Eisenberg T,
    2. Knauer H,
    3. Schauer A,
    4. et al
    . Induction of autophagy by spermidine promotes longevity. Nat Cell Biol. 2009;11:1305–1314. doi: 10.1038/ncb1975.
    OpenUrlCrossRefPubMed
  74. 74.↵
    1. Haigis MC,
    2. Sinclair DA.
    Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol. 2010;5:253–295. doi: 10.1146/annurev.pathol.4.110807.092250.
    OpenUrlCrossRefPubMed
  75. 75.↵
    1. Alcendor RR,
    2. Gao S,
    3. Zhai P,
    4. Zablocki D,
    5. Holle E,
    6. Yu X,
    7. Tian B,
    8. Wagner T,
    9. Vatner SF,
    10. Sadoshima J.
    Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res. 2007;100:1512–1521. doi: 10.1161/01.RES.0000267723.65696.4a.
    OpenUrlAbstract/FREE Full Text
  76. 76.↵
    1. Alcendor RR,
    2. Kirshenbaum LA,
    3. Imai S,
    4. Vatner SF,
    5. Sadoshima J.
    Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ Res. 2004;95:971–980. doi: 10.1161/01.RES.0000147557.75257.ff.
    OpenUrlAbstract/FREE Full Text
  77. 77.↵
    1. Hariharan N,
    2. Maejima Y,
    3. Nakae J,
    4. Paik J,
    5. Depinho RA,
    6. Sadoshima J.
    Deacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes. Circ Res. 2010;107:1470–1482. doi: 10.1161/CIRCRESAHA.110.227371.
    OpenUrlAbstract/FREE Full Text
  78. 78.↵
    1. Zhou S,
    2. Chen HZ,
    3. Wan YZ,
    4. Zhang QJ,
    5. Wei YS,
    6. Huang S,
    7. Liu JJ,
    8. Lu YB,
    9. Zhang ZQ,
    10. Yang RF,
    11. Zhang R,
    12. Cai H,
    13. Liu DP,
    14. Liang CC.
    Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circ Res. 2011;109:639–648. doi: 10.1161/CIRCRESAHA.111.243592.
    OpenUrlAbstract/FREE Full Text
  79. 79.↵
    1. Migliaccio E,
    2. Giorgio M,
    3. Mele S,
    4. Pelicci G,
    5. Reboldi P,
    6. Pandolfi PP,
    7. Lanfrancone L,
    8. Pelicci PG.
    The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature. 1999;402:309–313. doi: 10.1038/46311.
    OpenUrlCrossRefPubMed
  80. 80.↵
    1. Nemoto S,
    2. Finkel T.
    Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science. 2002;295:2450–2452. doi: 10.1126/science.1069004.
    OpenUrlAbstract/FREE Full Text
  81. 81.↵
    1. Giorgio M,
    2. Migliaccio E,
    3. Orsini F,
    4. Paolucci D,
    5. Moroni M,
    6. Contursi C,
    7. Pelliccia G,
    8. Luzi L,
    9. Minucci S,
    10. Marcaccio M,
    11. Pinton P,
    12. Rizzuto R,
    13. Bernardi P,
    14. Paolucci F,
    15. Pelicci PG.
    Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell. 2005;122:221–233. doi: 10.1016/j.cell.2005.05.011.
    OpenUrlCrossRefPubMed
  82. 82.↵
    1. Nemoto S,
    2. Combs CA,
    3. French S,
    4. Ahn BH,
    5. Fergusson MM,
    6. Balaban RS,
    7. Finkel T.
    The mammalian longevity-associated gene product p66shc regulates mitochondrial metabolism. J Biol Chem. 2006;281:10555–10560. doi: 10.1074/jbc.M511626200.
    OpenUrlAbstract/FREE Full Text
  83. 83.↵
    1. Ahn BH,
    2. Kim HS,
    3. Song S,
    4. Lee IH,
    5. Liu J,
    6. Vassilopoulos A,
    7. Deng CX,
    8. Finkel T.
    A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci U S A. 2008;105:14447–14452. doi: 10.1073/pnas.0803790105.
    OpenUrlAbstract/FREE Full Text
  84. 84.↵
    1. Hafner AV,
    2. Dai J,
    3. Gomes AP,
    4. Xiao CY,
    5. Palmeira CM,
    6. Rosenzweig A,
    7. Sinclair DA.
    Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging (Albany NY). 2010;2:914–923.
    OpenUrlPubMed
  85. 85.↵
    1. Sack MN.
    The role of SIRT3 in mitochondrial homeostasis and cardiac adaptation to hypertrophy and aging. J Mol Cell Cardiol. 2012;52:520–525. doi: 10.1016/j.yjmcc.2011.11.004.
    OpenUrlCrossRefPubMed
  86. 86.↵
    1. Sciarretta S,
    2. Volpe M,
    3. Sadoshima J.
    Mammalian target of rapamycin signaling in cardiac physiology and disease. Circ Res. 2014;114:549–564. doi: 10.1161/CIRCRESAHA.114.302022.
    OpenUrlAbstract/FREE Full Text
  87. 87.↵
    1. Kim J,
    2. Kundu M,
    3. Viollet B,
    4. Guan KL.
    AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13:132–141. doi: 10.1038/ncb2152.
    OpenUrlCrossRefPubMed
  88. 88.↵
    1. Harrison DE,
    2. Strong R,
    3. Sharp ZD,
    4. Nelson JF,
    5. Astle CM,
    6. Flurkey K,
    7. Nadon NL,
    8. Wilkinson JE,
    9. Frenkel K,
    10. Carter CS,
    11. Pahor M,
    12. Javors MA,
    13. Fernandez E,
    14. Miller RA.
    Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460:392–395. doi: 10.1038/nature08221.
    OpenUrlCrossRefPubMed
  89. 89.↵
    1. Baar EL,
    2. Carbajal KA,
    3. Ong IM,
    4. Lamming DW.
    Sex- and tissue-specific changes in mTOR signaling with age in C57BL/6J mice. Aging Cell. 2016;15:155–166. doi: 10.1111/acel.12425.
    OpenUrlCrossRefPubMed
  90. 90.↵
    1. Loffredo FS,
    2. Steinhauser ML,
    3. Jay SM,
    4. et al
    . Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell. 2013;153:828–839. doi: 10.1016/j.cell.2013.04.015.
    OpenUrlCrossRefPubMed
  91. 91.↵
    1. Smith SC,
    2. Zhang X,
    3. Zhang X,
    4. et al
    . GDF11 does not rescue aging-related pathological hypertrophy. Circ Res. 2015;117:926–932. doi: 10.1161/CIRCRESAHA.115.307527.
    OpenUrlAbstract/FREE Full Text
  92. 92.↵
    1. Sinha M,
    2. Jang YC,
    3. Oh J,
    4. et al
    . Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science. 2014;344:649–652. doi: 10.1126/science.1251152.
    OpenUrlAbstract/FREE Full Text
  93. 93.↵
    1. Stadtman ER.
    Protein oxidation in aging and age-related diseases. Ann N Y Acad Sci. 2001;928:22–38.
    OpenUrlCrossRefPubMed
  94. 94.↵
    1. Gatica D,
    2. Chiong M,
    3. Lavandero S,
    4. Klionsky DJ.
    Molecular mechanisms of autophagy in the cardiovascular system. Circ Res. 2015;116:456–467. doi: 10.1161/CIRCRESAHA.114.303788.
    OpenUrlAbstract/FREE Full Text
  95. 95.↵
    1. Hwang S,
    2. Disatnik MH,
    3. Mochly-Rosen D.
    Impaired GAPDH-induced mitophagy contributes to the pathology of Huntington’s disease. EMBO Mol Med. 2015;7:1307–1326. doi: 10.15252/emmm.201505256.
    OpenUrlAbstract/FREE Full Text
  96. 96.↵
    1. Taneike M,
    2. Yamaguchi O,
    3. Nakai A,
    4. et al
    . Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy. 2010;6:600–606. doi: 10.4161/auto.6.5.11947.
    OpenUrlCrossRefPubMed
  97. 97.↵
    1. Blanchet FP,
    2. Moris A,
    3. Nikolic DS,
    4. Lehmann M,
    5. Cardinaud S,
    6. Stalder R,
    7. Garcia E,
    8. Dinkins C,
    9. Leuba F,
    10. Wu L,
    11. Schwartz O,
    12. Deretic V,
    13. Piguet V.
    Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. Immunity. 2010;32:654–669. doi: 10.1016/j.immuni.2010.04.011.
    OpenUrlCrossRefPubMed
  98. 98.↵
    1. Huang C,
    2. Yitzhaki S,
    3. Perry CN,
    4. Liu W,
    5. Giricz Z,
    6. Mentzer RM Jr.,
    7. Gottlieb RA.
    Autophagy induced by ischemic preconditioning is essential for cardioprotection. J Cardiovasc Transl Res. 2010;3:365–373. doi: 10.1007/s12265-010-9189-3.
    OpenUrlCrossRefPubMed
  99. 99.↵
    1. Maejima Y,
    2. Kyoi S,
    3. Zhai P,
    4. Liu T,
    5. Li H,
    6. Ivessa A,
    7. Sciarretta S,
    8. Del Re DP,
    9. Zablocki DK,
    10. Hsu CP,
    11. Lim DS,
    12. Isobe M,
    13. Sadoshima J.
    Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2. Nat Med. 2013;19:1478–1488. doi: 10.1038/nm.3322.
    OpenUrlCrossRefPubMed
  100. 100.↵
    1. Sciarretta S,
    2. Zhai P,
    3. Shao D,
    4. Maejima Y,
    5. Robbins J,
    6. Volpe M,
    7. Condorelli G,
    8. Sadoshima J.
    Rheb is a critical regulator of autophagy during myocardial ischemia: pathophysiological implications in obesity and metabolic syndrome. Circulation. 2012;125:1134–1146. doi: 10.1161/CIRCULATIONAHA.111.078212.
    OpenUrlAbstract/FREE Full Text
  101. 101.↵
    1. Liao X,
    2. Zhang R,
    3. Lu Y,
    4. et al
    . Kruppel-like factor 4 is critical for transcriptional control of cardiac mitochondrial homeostasis. J Clin Invest. 2015;125:3461–3476. doi: 10.1172/JCI79964.
    OpenUrlCrossRefPubMed
  102. 102.↵
    1. Chauhan S,
    2. Goodwin JG,
    3. Chauhan S,
    4. Manyam G,
    5. Wang J,
    6. Kamat AM,
    7. Boyd DD.
    ZKSCAN3 is a master transcriptional repressor of autophagy. Mol Cell. 2013;50:16–28. doi: 10.1016/j.molcel.2013.01.024.
    OpenUrlCrossRefPubMed
  103. 103.↵
    1. Menghini R,
    2. Casagrande V,
    3. Marino A,
    4. Marchetti V,
    5. Cardellini M,
    6. Stoehr R,
    7. Rizza S,
    8. Martelli E,
    9. Greco S,
    10. Mauriello A,
    11. Ippoliti A,
    12. Martelli F,
    13. Lauro R,
    14. Federici M.
    MiR-216a: a link between endothelial dysfunction and autophagy. Cell Death Dis. 2014;5:e1029. doi: 10.1038/cddis.2013.556.
    OpenUrlCrossRefPubMed
  104. 104.↵
    1. Zaglia T,
    2. Milan G,
    3. Ruhs A,
    4. Franzoso M,
    5. Bertaggia E,
    6. Pianca N,
    7. Carpi A,
    8. Carullo P,
    9. Pesce P,
    10. Sacerdoti D,
    11. Sarais C,
    12. Catalucci D,
    13. Krüger M,
    14. Mongillo M,
    15. Sandri M.
    Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy. J Clin Invest. 2014;124:2410–2424. doi: 10.1172/JCI66339.
    OpenUrlCrossRefPubMed
  105. 105.↵
    1. Enot DP,
    2. Niso-Santano M,
    3. Durand S,
    4. Chery A,
    5. Pietrocola F,
    6. Vacchelli E,
    7. Madeo F,
    8. Galluzzi L,
    9. Kroemer G.
    Metabolomic analyses reveal that anti-aging metabolites are depleted by palmitate but increased by oleate in vivo. Cell Cycle. 2015;14:2399–2407. doi: 10.1080/15384101.2015.1064206.
    OpenUrlCrossRefPubMed
  106. 106.↵
    1. Tóth ML,
    2. Sigmond T,
    3. Borsos E,
    4. Barna J,
    5. Erdélyi P,
    6. Takács-Vellai K,
    7. Orosz L,
    8. Kovács AL,
    9. Csikós G,
    10. Sass M,
    11. Vellai T.
    Longevity pathways converge on autophagy genes to regulate life span in Caenorhabditis elegans. Autophagy. 2008;4:330–338.
    OpenUrlCrossRefPubMed
  107. 107.↵
    1. Matecic M,
    2. Smith DL,
    3. Pan X,
    4. Maqani N,
    5. Bekiranov S,
    6. Boeke JD,
    7. Smith JS.
    A microarray-based genetic screen for yeast chronological aging factors. PLoS Genet. 2010;6:e1000921. doi: 10.1371/journal.pgen.1000921.
    OpenUrlCrossRefPubMed
  108. 108.↵
    1. Lee JH,
    2. Budanov AV,
    3. Park EJ,
    4. Birse R,
    5. Kim TE,
    6. Perkins GA,
    7. Ocorr K,
    8. Ellisman MH,
    9. Bodmer R,
    10. Bier E,
    11. Karin M.
    Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies. Science. 2010;327:1223–1228. doi: 10.1126/science.1182228.
    OpenUrlAbstract/FREE Full Text
  109. 109.↵
    1. Simonsen A,
    2. Cumming RC,
    3. Brech A,
    4. Isakson P,
    5. Schubert DR,
    6. Finley KD.
    Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila. Autophagy. 2008;4:176–184.
    OpenUrlCrossRefPubMed
  110. 110.↵
    1. Vellai T.
    Autophagy genes and ageing. Cell Death Differ. 2009;16:94–102. doi: 10.1038/cdd.2008.126.
    OpenUrlCrossRefPubMed
  111. 111.↵
    1. Hartleben B,
    2. Gödel M,
    3. Meyer-Schwesinger C,
    4. et al
    . Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest. 2010;120:1084–1096. doi: 10.1172/JCI39492.
    OpenUrlCrossRefPubMed
  112. 112.↵
    1. Komatsu M,
    2. Kurokawa H,
    3. Waguri S,
    4. et al
    . The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol. 2010;12:213–223. doi: 10.1038/ncb2021.
    OpenUrlCrossRefPubMed
  113. 113.↵
    1. Mathew R,
    2. Karp CM,
    3. Beaudoin B,
    4. Vuong N,
    5. Chen G,
    6. Chen HY,
    7. Bray K,
    8. Reddy A,
    9. Bhanot G,
    10. Gelinas C,
    11. Dipaola RS,
    12. Karantza-Wadsworth V,
    13. White E.
    Autophagy suppresses tumorigenesis through elimination of p62. Cell. 2009;137:1062–1075. doi: 10.1016/j.cell.2009.03.048.
    OpenUrlCrossRefPubMed
  114. 114.↵
    1. Wu JJ,
    2. Quijano C,
    3. Chen E,
    4. Liu H,
    5. Cao L,
    6. Fergusson MM,
    7. Rovira II,
    8. Gutkind S,
    9. Daniels MP,
    10. Komatsu M,
    11. Finkel T.
    Mitochondrial dysfunction and oxidative stress mediate the physiological impairment induced by the disruption of autophagy. Aging (Albany NY). 2009;1:425–437.
    OpenUrlPubMed
  115. 115.↵
    1. Yang L,
    2. Li P,
    3. Fu S,
    4. Calay ES,
    5. Hotamisligil GS.
    Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 2010;11:467–478. doi: 10.1016/j.cmet.2010.04.005.
    OpenUrlCrossRefPubMed
  116. 116.↵
    1. Gupta VK,
    2. Scheunemann L,
    3. Eisenberg T,
    4. et al
    . Restoring polyamines protects from age-induced memory impairment in an autophagy-dependent manner. Nat Neurosci. 2013;16:1453–1460. doi: 10.1038/nn.3512.
    OpenUrlCrossRefPubMed
  117. 117.↵
    1. Nakahira K,
    2. Haspel JA,
    3. Rathinam VA,
    4. Lee SJ,
    5. Dolinay T,
    6. Lam HC,
    7. Englert JA,
    8. Rabinovitch M,
    9. Cernadas M,
    10. Kim HP,
    11. Fitzgerald KA,
    12. Ryter SW,
    13. Choi AM.
    Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol. 2011;12:222–230. doi: 10.1038/ni.1980.
    OpenUrlCrossRefPubMed
  118. 118.↵
    1. Levine B,
    2. Mizushima N,
    3. Virgin HW.
    Autophagy in immunity and inflammation. Nature. 2011;469:323–335. doi: 10.1038/nature09782.
    OpenUrlCrossRefPubMed
  119. 119.↵
    1. Singh R,
    2. Kaushik S,
    3. Wang Y,
    4. Xiang Y,
    5. Novak I,
    6. Komatsu M,
    7. Tanaka K,
    8. Cuervo AM,
    9. Czaja MJ.
    Autophagy regulates lipid metabolism. Nature. 2009;458:1131–1135. doi: 10.1038/nature07976.
    OpenUrlCrossRefPubMed
  120. 120.↵
    1. Zhou J,
    2. Force T.
    Focusing the spotlight on GSK-3 in aging. Aging (Albany NY). 2013;5:388–389.
    OpenUrlPubMed
  121. 121.↵
    1. Agah R,
    2. Frenkel PA,
    3. French BA,
    4. Michael LH,
    5. Overbeek PA,
    6. Schneider MD.
    Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J Clin Invest. 1997;100:169–179. doi: 10.1172/JCI119509.
    OpenUrlCrossRefPubMed
  122. 122.↵
    1. Walter S,
    2. Atzmon G,
    3. Demerath EW,
    4. et al
    . A genome-wide association study of aging. Neurobiol Aging. 2011;32:2109.e15–2109.e28. doi: 10.1016/j.neurobiolaging.2011.05.026.
    OpenUrlCrossRefPubMed
  123. 123.↵
    1. Uchiki T,
    2. Weikel KA,
    3. Jiao W,
    4. Shang F,
    5. Caceres A,
    6. Pawlak D,
    7. Handa JT,
    8. Brownlee M,
    9. Nagaraj R,
    10. Taylor A.
    Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics). Aging Cell. 2012;11:1–13. doi: 10.1111/j.1474-9726.2011.00752.x.
    OpenUrlCrossRefPubMed
  124. 124.↵
    1. Pattison JS,
    2. Osinska H,
    3. Robbins J.
    Atg7 induces basal autophagy and rescues autophagic deficiency in CryABR120G cardiomyocytes. Circ Res. 2011;109:151–160. doi: 10.1161/CIRCRESAHA.110.237339.
    OpenUrlAbstract/FREE Full Text
  125. 125.↵
    1. Zhang C,
    2. Cuervo AM.
    Restoration of chaperone-mediated autophagy in aging liver improves cellular maintenance and hepatic function. Nat Med. 2008;14:959–965. doi: 10.1038/nm.1851.
    OpenUrlCrossRefPubMed
  126. 126.↵
    1. Ikeda Y,
    2. Shirakabe A,
    3. Maejima Y,
    4. Zhai P,
    5. Sciarretta S,
    6. Toli J,
    7. Nomura M,
    8. Mihara K,
    9. Egashira K,
    10. Ohishi M,
    11. Abdellatif M,
    12. Sadoshima J.
    Endogenous Drp1 mediates mitochondrial autophagy and protects the heart against energy stress. Circ Res. 2015;116:264–278. doi: 10.1161/CIRCRESAHA.116.303356.
    OpenUrlAbstract/FREE Full Text
  127. 127.↵
    1. Saito T,
    2. Sadoshima J.
    Molecular mechanisms of mitochondrial autophagy/mitophagy in the heart. Circ Res. 2015;116:1477–1490. doi: 10.1161/CIRCRESAHA.116.303790.
    OpenUrlAbstract/FREE Full Text
  128. 128.↵
    1. Chen Y,
    2. Dorn GW II..
    PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria. Science. 2013;340:471–475. doi: 10.1126/science.1231031.
    OpenUrlAbstract/FREE Full Text
  129. 129.↵
    1. Lazarou M,
    2. Sliter DA,
    3. Kane LA,
    4. Sarraf SA,
    5. Wang C,
    6. Burman JL,
    7. Sideris DP,
    8. Fogel AI,
    9. Youle RJ.
    The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 2015;524:309–314. doi: 10.1038/nature14893.
    OpenUrlCrossRefPubMed
  130. 130.↵
    1. Kageyama Y,
    2. Hoshijima M,
    3. Seo K,
    4. Bedja D,
    5. Sysa-Shah P,
    6. Andrabi SA,
    7. Chen W,
    8. Höke A,
    9. Dawson VL,
    10. Dawson TM,
    11. Gabrielson K,
    12. Kass DA,
    13. Iijima M,
    14. Sesaki H.
    Parkin-independent mitophagy requires Drp1 and maintains the integrity of mammalian heart and brain. EMBO J. 2014;33:2798–2813. doi: 10.15252/embj.201488658.
    OpenUrlAbstract/FREE Full Text
  131. 131.↵
    1. Hirota Y,
    2. Yamashita S,
    3. Kurihara Y,
    4. Jin X,
    5. Aihara M,
    6. Saigusa T,
    7. Kang D,
    8. Kanki T.
    Mitophagy is primarily due to alternative autophagy and requires the MAPK1 and MAPK14 signaling pathways. Autophagy. 2015;11:332–343. doi: 10.1080/15548627.2015.1023047.
    OpenUrlCrossRefPubMed
  132. 132.↵
    1. Palikaras K,
    2. Lionaki E,
    3. Tavernarakis N.
    Coordination of mitophagy and mitochondrial biogenesis during ageing in C. elegans. Nature. 2015;521:525–528. doi: 10.1038/nature14300.
    OpenUrlCrossRefPubMed
  133. 133.↵
    1. Kubli DA,
    2. Quinsay MN,
    3. Gustafsson AB.
    Parkin deficiency results in accumulation of abnormal mitochondria in aging myocytes. Commun Integr Biol. 2013;6:e24511. doi: 10.4161/cib.24511.
    OpenUrlCrossRefPubMed
  134. 134.↵
    1. Kim KY,
    2. Stevens MV,
    3. Akter MH,
    4. Rusk SE,
    5. Huang RJ,
    6. Cohen A,
    7. Noguchi A,
    8. Springer D,
    9. Bocharov AV,
    10. Eggerman TL,
    11. Suen DF,
    12. Youle RJ,
    13. Amar M,
    14. Remaley AT,
    15. Sack MN.
    Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells. J Clin Invest. 2011;121:3701–3712. doi: 10.1172/JCI44736.
    OpenUrlCrossRefPubMed
  135. 135.↵
    1. Ferree AW,
    2. Trudeau K,
    3. Zik E,
    4. Benador IY,
    5. Twig G,
    6. Gottlieb RA,
    7. Shirihai OS.
    MitoTimer probe reveals the impact of autophagy, fusion, and motility on subcellular distribution of young and old mitochondrial protein and on relative mitochondrial protein age. Autophagy. 2013;9:1887–1896. doi: 10.4161/auto.26503.
    OpenUrlCrossRefPubMed
  136. 136.↵
    1. Stotland A,
    2. Gottlieb RA.
    α-MHC MitoTimer mouse: In vivo mitochondrial turnover model reveals remarkable mitochondrial heterogeneity in the heart. J Mol Cell Cardiol. 2016;90:53–58. doi: 10.1016/j.yjmcc.2015.11.032.
    OpenUrlCrossRefPubMed
  137. 137.↵
    1. Lin SJ,
    2. Defossez PA,
    3. Guarente L.
    Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science. 2000;289:2126–2128.
    OpenUrlAbstract/FREE Full Text
  138. 138.↵
    1. Rogina B,
    2. Helfand SL.
    Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci U S A. 2004;101:15998–16003. doi: 10.1073/pnas.0404184101.
    OpenUrlAbstract/FREE Full Text
  139. 139.↵
    1. Cohen HY,
    2. Miller C,
    3. Bitterman KJ,
    4. Wall NR,
    5. Hekking B,
    6. Kessler B,
    7. Howitz KT,
    8. Gorospe M,
    9. de Cabo R,
    10. Sinclair DA.
    Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science. 2004;305:390–392. doi: 10.1126/science.1099196.
    OpenUrlAbstract/FREE Full Text
  140. 140.↵
    1. Matsushima S,
    2. Sadoshima J.
    The role of sirtuins in cardiac disease. Am J Physiol Heart Circ Physiol. 2015;309:H1375–H1389. doi: 10.1152/ajpheart.00053.2015.
    OpenUrlAbstract/FREE Full Text
  141. 141.↵
    1. Yamamoto T,
    2. Sadoshima J.
    Protection of the heart against ischemia/reperfusion by silent information regulator 1. Trends Cardiovasc Med. 2011;21:27–32. doi: 10.1016/j.tcm.2012.01.005.
    OpenUrlCrossRefPubMed
  142. 142.↵
    1. Wood JG,
    2. Rogina B,
    3. Lavu S,
    4. Howitz K,
    5. Helfand SL,
    6. Tatar M,
    7. Sinclair D.
    Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 2004;430:686–689. doi: 10.1038/nature02789.
    OpenUrlCrossRefPubMed
  143. 143.↵
    1. Fabrizio P,
    2. Gattazzo C,
    3. Battistella L,
    4. Wei M,
    5. Cheng C,
    6. McGrew K,
    7. Longo VD.
    Sir2 blocks extreme life-span extension. Cell. 2005;123:655–667. doi: 10.1016/j.cell.2005.08.042.
    OpenUrlCrossRefPubMed
  144. 144.↵
    1. Luo J,
    2. Nikolaev AY,
    3. Imai S,
    4. Chen D,
    5. Su F,
    6. Shiloh A,
    7. Guarente L,
    8. Gu W.
    Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell. 2001;107:137–148.
    OpenUrlCrossRefPubMed
  145. 145.↵
    1. Vaziri H,
    2. Dessain SK,
    3. Ng Eaton E,
    4. Imai SI,
    5. Frye RA,
    6. Pandita TK,
    7. Guarente L,
    8. Weinberg RA.
    hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. 2001;107:149–159.
    OpenUrlCrossRefPubMed
  146. 146.↵
    1. Brunet A,
    2. Sweeney LB,
    3. Sturgill JF,
    4. et al
    . Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science. 2004;303:2011–2015. doi: 10.1126/science.1094637.
    OpenUrlAbstract/FREE Full Text
  147. 147.↵
    1. Motta MC,
    2. Divecha N,
    3. Lemieux M,
    4. Kamel C,
    5. Chen D,
    6. Gu W,
    7. Bultsma Y,
    8. McBurney M,
    9. Guarente L.
    Mammalian SIRT1 represses forkhead transcription factors. Cell. 2004;116:551–563.
    OpenUrlCrossRefPubMed
  148. 148.↵
    1. Daitoku H,
    2. Hatta M,
    3. Matsuzaki H,
    4. Aratani S,
    5. Ohshima T,
    6. Miyagishi M,
    7. Nakajima T,
    8. Fukamizu A.
    Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci U S A. 2004;101:10042–10047. doi: 10.1073/pnas.0400593101.
    OpenUrlAbstract/FREE Full Text
  149. 149.↵
    1. Smith J.
    Human Sir2 and the ‘silencing’ of p53 activity. Trends Cell Biol. 2002;12:404–406.
    OpenUrlCrossRefPubMed
  150. 150.↵
    1. Cheng HL,
    2. Mostoslavsky R,
    3. Saito S,
    4. Manis JP,
    5. Gu Y,
    6. Patel P,
    7. Bronson R,
    8. Appella E,
    9. Alt FW,
    10. Chua KF.
    Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci U S A. 2003;100:10794–10799. doi: 10.1073/pnas.1934713100.
    OpenUrlAbstract/FREE Full Text
  151. 151.↵
    1. Picard F,
    2. Kurtev M,
    3. Chung N,
    4. Topark-Ngarm A,
    5. Senawong T,
    6. Machado De Oliveira R,
    7. Leid M,
    8. McBurney MW,
    9. Guarente L.
    Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature. 2004;429:771–776. doi: 10.1038/nature02583.
    OpenUrlCrossRefPubMed
  152. 152.↵
    1. Hsu CP,
    2. Zhai P,
    3. Yamamoto T,
    4. Maejima Y,
    5. Matsushima S,
    6. Hariharan N,
    7. Shao D,
    8. Takagi H,
    9. Oka S,
    10. Sadoshima J.
    Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation. 2010;122:2170–2182. doi: 10.1161/CIRCULATIONAHA.110.958033.
    OpenUrlAbstract/FREE Full Text
  153. 153.↵
    1. Qiu X,
    2. Brown K,
    3. Hirschey MD,
    4. Verdin E,
    5. Chen D.
    Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab. 2010;12:662–667. doi: 10.1016/j.cmet.2010.11.015.
    OpenUrlCrossRefPubMed
  154. 154.↵
    1. Someya S,
    2. Yu W,
    3. Hallows WC,
    4. Xu J,
    5. Vann JM,
    6. Leeuwenburgh C,
    7. Tanokura M,
    8. Denu JM,
    9. Prolla TA.
    Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell. 2010;143:802–812. doi: 10.1016/j.cell.2010.10.002.
    OpenUrlCrossRefPubMed
  155. 155.↵
    1. Verdin E.
    NAD+ in aging, metabolism, and neurodegeneration. Science. 2015;350:1208–1213. doi: 10.1126/science.aac4854.
    OpenUrlAbstract/FREE Full Text
  156. 156.↵
    1. Hsu CP,
    2. Oka S,
    3. Shao D,
    4. Hariharan N,
    5. Sadoshima J.
    Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ Res. 2009;105:481–491. doi: 10.1161/CIRCRESAHA.109.203703.
    OpenUrlAbstract/FREE Full Text
  157. 157.↵
    1. Hsu CP,
    2. Hariharan N,
    3. Alcendor RR,
    4. Oka S,
    5. Sadoshima J.
    Nicotinamide phosphoribosyltransferase regulates cell survival through autophagy in cardiomyocytes. Autophagy. 2009;5:1229–1231.
    OpenUrlCrossRefPubMed
  158. 158.↵
    1. Yamamoto T,
    2. Byun J,
    3. Zhai P,
    4. Ikeda Y,
    5. Oka S,
    6. Sadoshima J.
    Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion. PLoS One. 2014;9:e98972. doi: 10.1371/journal.pone.0098972.
    OpenUrlCrossRefPubMed
  159. 159.↵
    1. Kimura KD,
    2. Tissenbaum HA,
    3. Liu Y,
    4. Ruvkun G.
    daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science. 1997;277:942–946.
    OpenUrlAbstract/FREE Full Text
  160. 160.↵
    1. Murphy CT,
    2. McCarroll SA,
    3. Bargmann CI,
    4. Fraser A,
    5. Kamath RS,
    6. Ahringer J,
    7. Li H,
    8. Kenyon C.
    Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature. 2003;424:277–283. doi: 10.1038/nature01789.
    OpenUrlCrossRefPubMed
  161. 161.↵
    1. Honda Y,
    2. Honda S.
    The daf-2 gene network for longevity regulates oxidative stress resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans. FASEB J. 1999;13:1385–1393.
    OpenUrlAbstract/FREE Full Text
  162. 162.↵
    1. Fabrizio P,
    2. Pozza F,
    3. Pletcher SD,
    4. Gendron CM,
    5. Longo VD.
    Regulation of longevity and stress resistance by Sch9 in yeast. Science. 2001;292:288–290. doi: 10.1126/science.1059497.
    OpenUrlAbstract/FREE Full Text
  163. 163.↵
    1. Kops GJ,
    2. Dansen TB,
    3. Polderman PE,
    4. Saarloos I,
    5. Wirtz KW,
    6. Coffer PJ,
    7. Huang TT,
    8. Bos JL,
    9. Medema RH,
    10. Burgering BM.
    Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature. 2002;419:316–321. doi: 10.1038/nature01036.
    OpenUrlCrossRefPubMed
  164. 164.↵
    1. Holzenberger M,
    2. Dupont J,
    3. Ducos B,
    4. Leneuve P,
    5. Géloën A,
    6. Even PC,
    7. Cervera P,
    8. Le Bouc Y.
    IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature. 2003;421:182–187. doi: 10.1038/nature01298.
    OpenUrlCrossRefPubMed
  165. 165.↵
    1. Tatar M,
    2. Bartke A,
    3. Antebi A.
    The endocrine regulation of aging by insulin-like signals. Science. 2003;299:1346–1351. doi: 10.1126/science.1081447.
    OpenUrlAbstract/FREE Full Text
  166. 166.↵
    1. Kurosu H,
    2. Yamamoto M,
    3. Clark JD,
    4. et al
    . Suppression of aging in mice by the hormone Klotho. Science. 2005;309:1829–1833. doi: 10.1126/science.1112766.
    OpenUrlAbstract/FREE Full Text
  167. 167.↵
    1. Crow MT.
    Sir-viving cardiac stress: cardioprotection mediated by a longevity gene. Circ Res. 2004;95:953–956. doi: 10.1161/01.RES.0000148666.20729.1c.
    OpenUrlFREE Full Text
  168. 168.↵
    1. Anversa P.
    Aging and longevity: the IGF-1 enigma. Circ Res. 2005;97:411–414. doi: 10.1161/01.RES.0000182212.09147.56.
    OpenUrlFREE Full Text
  169. 169.↵
    1. Cattin ME,
    2. Wang J,
    3. Weldrick JJ,
    4. Roeske CL,
    5. Mak E,
    6. Thorn SL,
    7. DaSilva JN,
    8. Wang Y,
    9. Lusis AJ,
    10. Burgon PG.
    Deletion of MLIP (muscle-enriched A-type lamin-interacting protein) leads to cardiac hyperactivation of Akt/mammalian target of rapamycin (mTOR) and impaired cardiac adaptation. J Biol Chem. 2015;290:26699–26714. doi: 10.1074/jbc.M115.678433.
    OpenUrlAbstract/FREE Full Text
  170. 170.↵
    1. Hua Y,
    2. Zhang Y,
    3. Ceylan-Isik AF,
    4. Wold LE,
    5. Nunn JM,
    6. Ren J.
    Chronic Akt activation accentuates aging-induced cardiac hypertrophy and myocardial contractile dysfunction: role of autophagy. Basic Res Cardiol. 2011;106:1173–1191. doi: 10.1007/s00395-011-0222-8.
    OpenUrlCrossRefPubMed
  171. 171.↵
    1. Matsui Y,
    2. Takagi H,
    3. Qu X,
    4. Abdellatif M,
    5. Sakoda H,
    6. Asano T,
    7. Levine B,
    8. Sadoshima J.
    Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res. 2007;100:914–922. doi: 10.1161/01.RES.0000261924.76669.36.
    OpenUrlAbstract/FREE Full Text
  172. 172.↵
    1. Dai DF,
    2. Karunadharma PP,
    3. Chiao YA,
    4. Basisty N,
    5. Crispin D,
    6. Hsieh EJ,
    7. Chen T,
    8. Gu H,
    9. Djukovic D,
    10. Raftery D,
    11. Beyer RP,
    12. MacCoss MJ,
    13. Rabinovitch PS.
    Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart. Aging Cell. 2014;13:529–539. doi: 10.1111/acel.12203.
    OpenUrlCrossRefPubMed
  173. 173.↵
    1. Zhai P,
    2. Sciarretta S,
    3. Galeotti J,
    4. Volpe M,
    5. Sadoshima J.
    Differential roles of GSK-3β during myocardial ischemia and ischemia/reperfusion. Circ Res. 2011;109:502–511. doi: 10.1161/CIRCRESAHA.111.249532.
    OpenUrlAbstract/FREE Full Text
  174. 174.↵
    1. Zhou J,
    2. Freeman TA,
    3. Ahmad F,
    4. Shang X,
    5. Mangano E,
    6. Gao E,
    7. Farber J,
    8. Wang Y,
    9. Ma XL,
    10. Woodgett J,
    11. Vagnozzi RJ,
    12. Lal H,
    13. Force T.
    GSK-3α is a central regulator of age-related pathologies in mice. J Clin Invest. 2013;123:1821–1832. doi: 10.1172/JCI64398.
    OpenUrlCrossRefPubMed
  175. 175.↵
    1. Lal H,
    2. Ahmad F,
    3. Woodgett J,
    4. Force T.
    The GSK-3 family as therapeutic target for myocardial diseases. Circ Res. 2015;116:138–149. doi: 10.1161/CIRCRESAHA.116.303613.
    OpenUrlAbstract/FREE Full Text
  176. 176.↵
    1. Egan DF,
    2. Shackelford DB,
    3. Mihaylova MM,
    4. et al
    . Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science. 2011;331:456–461. doi: 10.1126/science.1196371.
    OpenUrlAbstract/FREE Full Text
  177. 177.↵
    1. Martin-Montalvo A,
    2. Mercken EM,
    3. Mitchell SJ,
    4. et al
    . Metformin improves healthspan and lifespan in mice. Nat Commun. 2013;4:2192. doi: 10.1038/ncomms3192.
    OpenUrlCrossRefPubMed
  178. 178.↵
    1. Turdi S,
    2. Fan X,
    3. Li J,
    4. Zhao J,
    5. Huff AF,
    6. Du M,
    7. Ren J.
    AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction. Aging Cell. 2010;9:592–606. doi: 10.1111/j.1474-9726.2010.00586.x.
    OpenUrlCrossRefPubMed
  179. 179.↵
    1. Ikeda Y,
    2. Sciarretta S,
    3. Nagarajan N,
    4. Rubattu S,
    5. Volpe M,
    6. Frati G,
    7. Sadoshima J.
    New insights into the role of mitochondrial dynamics and autophagy during oxidative stress and aging in the heart. Oxid Med Cell Longev. 2014;2014:210934. doi: 10.1155/2014/210934.
    OpenUrlCrossRefPubMed
  180. 180.↵
    1. Hariharan N,
    2. Zhai P,
    3. Sadoshima J.
    Oxidative stress stimulates autophagic flux during ischemia/reperfusion. Antioxid Redox Signal. 2011;14:2179–2190. doi: 10.1089/ars.2010.3488.
    OpenUrlCrossRefPubMed
  181. 181.↵
    1. Sciarretta S,
    2. Zhai P,
    3. Shao D,
    4. Zablocki D,
    5. Nagarajan N,
    6. Terada LS,
    7. Volpe M,
    8. Sadoshima J.
    Activation of NADPH oxidase 4 in the endoplasmic reticulum promotes cardiomyocyte autophagy and survival during energy stress through the protein kinase RNA-activated-like endoplasmic reticulum kinase/eukaryotic initiation factor 2α/activating transcription factor 4 pathway. Circ Res. 2013;113:1253–1264. doi: 10.1161/CIRCRESAHA.113.301787.
    OpenUrlAbstract/FREE Full Text
  182. 182.↵
    1. Koubova J,
    2. Guarente L.
    How does calorie restriction work? Genes Dev. 2003;17:313–321. doi: 10.1101/gad.1052903.
    OpenUrlFREE Full Text
  183. 183.↵
    1. Lin SJ,
    2. Kaeberlein M,
    3. Andalis AA,
    4. Sturtz LA,
    5. Defossez PA,
    6. Culotta VC,
    7. Fink GR,
    8. Guarente L.
    Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration. Nature. 2002;418:344–348. doi: 10.1038/nature00829.
    OpenUrlCrossRefPubMed
  184. 184.↵
    1. Lamming DW,
    2. Latorre-Esteves M,
    3. Medvedik O,
    4. Wong SN,
    5. Tsang FA,
    6. Wang C,
    7. Lin SJ,
    8. Sinclair DA.
    HST2 mediates SIR2-independent life-span extension by calorie restriction. Science. 2005;309:1861–1864. doi: 10.1126/science.1113611.
    OpenUrlAbstract/FREE Full Text
  185. 185.↵
    1. Sohal RS,
    2. Weindruch R.
    Oxidative stress, caloric restriction, and aging. Science. 1996;273:59–63.
    OpenUrlAbstract/FREE Full Text
  186. 186.↵
    1. Kaeberlein M,
    2. Powers RW III.,
    3. Steffen KK,
    4. Westman EA,
    5. Hu D,
    6. Dang N,
    7. Kerr EO,
    8. Kirkland KT,
    9. Fields S,
    10. Kennedy BK.
    Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science. 2005;310:1193–1196. doi: 10.1126/science.1115535.
    OpenUrlAbstract/FREE Full Text
  187. 187.↵
    1. Ramos FJ,
    2. Chen SC,
    3. Garelick MG,
    4. Dai DF,
    5. Liao CY,
    6. Schreiber KH,
    7. MacKay VL,
    8. An EH,
    9. Strong R,
    10. Ladiges WC,
    11. Rabinovitch PS,
    12. Kaeberlein M,
    13. Kennedy BK.
    Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival. Sci Transl Med. 2012;4:144ra103. doi: 10.1126/scitranslmed.3003802.
    OpenUrlAbstract/FREE Full Text
  188. 188.↵
    1. Turturro A,
    2. Duffy P,
    3. Hass B,
    4. Kodell R,
    5. Hart R.
    Survival characteristics and age-adjusted disease incidences in C57BL/6 mice fed a commonly used cereal-based diet modulated by dietary restriction. J Gerontol A Biol Sci Med Sci. 2002;57:B379–B389.
    OpenUrlAbstract/FREE Full Text
  189. 189.↵
    1. Shinmura K,
    2. Tamaki K,
    3. Sano M,
    4. Murata M,
    5. Yamakawa H,
    6. Ishida H,
    7. Fukuda K.
    Impact of long-term caloric restriction on cardiac senescence: caloric restriction ameliorates cardiac diastolic dysfunction associated with aging. J Mol Cell Cardiol. 2011;50:117–127. doi: 10.1016/j.yjmcc.2010.10.018.
    OpenUrlCrossRefPubMed
  190. 190.↵
    1. Tocchi A,
    2. Quarles EK,
    3. Basisty N,
    4. Gitari L,
    5. Rabinovitch PS.
    Mitochondrial dysfunction in cardiac aging. Biochim Biophys Acta. 2015;1847:1424–1433. doi: 10.1016/j.bbabio.2015.07.009.
    OpenUrl
  191. 191.↵
    1. He C,
    2. Bassik MC,
    3. Moresi V,
    4. et al
    . Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature. 2012;481:511–515. doi: 10.1038/nature10758.
    OpenUrlCrossRefPubMed
  192. 192.↵
    1. Bhuiyan MS,
    2. Pattison JS,
    3. Osinska H,
    4. James J,
    5. Gulick J,
    6. McLendon PM,
    7. Hill JA,
    8. Sadoshima J,
    9. Robbins J.
    Enhanced autophagy ameliorates cardiac proteinopathy. J Clin Invest. 2013;123:5284–5297. doi: 10.1172/JCI70877.
    OpenUrlCrossRefPubMed
  193. 193.↵
    1. Lu K,
    2. Psakhye I,
    3. Jentsch S.
    Autophagic clearance of polyQ proteins mediated by ubiquitin-Atg8 adaptors of the conserved CUET protein family. Cell. 2014;158:549–563. doi: 10.1016/j.cell.2014.05.048.
    OpenUrlCrossRefPubMed
  194. 194.↵
    1. Wan N,
    2. Liu X,
    3. Zhang XJ,
    4. Zhao Y,
    5. Hu G,
    6. Wan F,
    7. Zhang R,
    8. Zhu X,
    9. Xia H,
    10. Li H.
    Toll-interacting protein contributes to mortality following myocardial infarction through promoting inflammation and apoptosis. Br J Pharmacol. 2015;172:3383–3396. doi: 10.1111/bph.13130.
    OpenUrlCrossRefPubMed
  195. 195.↵
    1. Williams B,
    2. Njaci I,
    3. Moghaddam L,
    4. Long H,
    5. Dickman MB,
    6. Zhang X,
    7. Mundree S.
    Trehalose accumulation triggers autophagy during plant desiccation. PLoS Genet. 2015;11:e1005705. doi: 10.1371/journal.pgen.1005705.
    OpenUrlCrossRefPubMed
  196. 196.↵
    1. Sciarretta S,
    2. Zhai P,
    3. Volpe M,
    4. Sadoshima J.
    Trehalose, a natural dissachride, reduces cardiac remodeling after myocardial infarction through autophagy activation. Circulation. 2012;126:A18096.
    OpenUrl
  197. 197.↵
    1. Boon RA,
    2. Iekushi K,
    3. Lechner S,
    4. et al
    . MicroRNA-34a regulates cardiac ageing and function. Nature. 2013;495:107–110. doi: 10.1038/nature11919.
    OpenUrlCrossRefPubMed
  198. 198.↵
    1. Liang N,
    2. Zhang C,
    3. Dill P,
    4. et al
    . Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex. J Exp Med. 2014;211:2249–2263. doi: 10.1084/jem.20140341.
    OpenUrlAbstract/FREE Full Text
  199. 199.↵
    1. Cantó C,
    2. Menzies KJ,
    3. Auwerx J.
    NAD(+) Metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab. 2015;22:31–53. doi: 10.1016/j.cmet.2015.05.023.
    OpenUrlCrossRefPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Circulation Research
May 13, 2016, Volume 118, Issue 10
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Abstract
    • Manifestation of Aging in the Heart
    • Molecular Mechanisms of Aging in the Heart
    • Role of Autophagy During Aging of the Heart
    • Role of Mitophagy
    • Relevant Intracellular Signaling Mechanisms Controlling Autophagy During Aging
    • How to Stimulate Autophagy
    • Concluding Remarks
    • Acknowledgments
    • Sources of Funding
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics

Article Tools

  • Print
  • Citation Tools
    Aging and Autophagy in the Heart
    Akihiro Shirakabe, Yoshiyuki Ikeda, Sebastiano Sciarretta, Daniela K. Zablocki and Junichi Sadoshima
    Circulation Research. 2016;118:1563-1576, originally published May 12, 2016
    https://doi.org/10.1161/CIRCRESAHA.116.307474

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation Research.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Aging and Autophagy in the Heart
    (Your Name) has sent you a message from Circulation Research
    (Your Name) thought you would like to see the Circulation Research web site.
  • Share on Social Media
    Aging and Autophagy in the Heart
    Akihiro Shirakabe, Yoshiyuki Ikeda, Sebastiano Sciarretta, Daniela K. Zablocki and Junichi Sadoshima
    Circulation Research. 2016;118:1563-1576, originally published May 12, 2016
    https://doi.org/10.1161/CIRCRESAHA.116.307474
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Basic, Translational, and Clinical Research
    • Metabolism
    • Myocardial Biology
    • Cell Signaling/Signal Transduction

Circulation Research

  • About Circulation Research
  • Editorial Board
  • Instructions for Authors
  • Abstract Supplements
  • AHA Statements and Guidelines
  • Permissions
  • Reprints
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
3355 Keswick Rd
Main Bldg 103
Baltimore, MD 21211
CircRes@circresearch.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured